, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LKQ Corporation ("LKQ" or the "Company") (NASDAQ: LKQ). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether LKQ and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until June 22, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired LKQ securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
[Click here for information about joining the class action]
In February 2023, LKQ announced plans to acquire its competitor, Uni-Select Incorporated ("Uni-Select"), including Uni-Select's United States operating subsidiary, FinishMaster.
On April 23, 2024, LKQ lowered its financial guidance, citing slow demand in its North American segment, where FinishMaster was being integrated. LKQ also announced that CEO Dominick Zarcone, who oversaw the Uni-Select acquisition, was leaving the Company.
On this news, LKQ's stock price fell $7.28 per share, or 14.9%, to close at $41.65 per share on April 23, 2024.
Then, on July 25, 2024, LKQ reported disappointing earnings for its second fiscal quarter of 2024. LKQ revealed that it had missed revenue estimates for the quarter and further lowered its financial guidance for the rest of the fiscal year, again blaming slowing demand on its North American segment.
On these disclosures, LKQ's stock price fell $5.53 per share, or 12.4%, to close at $38.95 per share on July 25, 2024.
On October 24, 2024, LKQ revealed that the FinishMaster business was, in fact, losing business, including major customers, to LKQ's competitors. LKQ revealed that these losses began "pre-acquisition or pre-closing and leading into post-acquisition." Then, on April 24, 2025, LKQ revealed that its North American market segment, where FinishMaster was now fully integrated, had continued to lose market share due to competitors consistently undercutting LKQ on price, causing LKQ to miss revenue and margin targets.
Following these disclosures, LKQ's stock price fell $4.87 perf share, or 11.6%, to close at $37.26 per share on April 24, 2025.
Finally, on July 24, 2025, LKQ disclosed that its worsening market share losses had caused the Company to miss margin targets again.
On this news, LKQ's stock price fell $6.88 per share, or 17.8%, to close at $31.73 per share on July 24, 2025.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
New York, New York--(Newsfile Corp. - June 18, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against LKQ Corporation (NASDAQ: LKQ) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired LKQ securities between February 27, 2023 and July 23, 2025, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/LKQ.
LKQ Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
LKQ's acquisition and integration of FinishMaster did not present the "minimal integration risk" Defendants had represented; the acquisition was not the "compelling strategic fit" purported to enhance LKQ's business and drive profitable growth; FinishMaster did not meaningfully improve LKQ's scale or product mix to compete in the North American automotive paint segment as touted; and as a result, Defendants' public statements regarding the acquisition, integration prospects, and related benefits were materially false and misleading at all relevant times.What's Next for LKQ Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/LKQ, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in LKQ you have until June 22, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to LKQ Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for LKQ Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising.
Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294709
Source: Bronstein, Gewirtz & Grossman, LLC
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of LKQ Corporation (NASDAQ: LKQ).
Shareholders who purchased shares of LKQ during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
ALLEGATIONS: According to the filed complaint, during the class period, defendants made materially false and misleading statements and omissions, and engaged in a scheme to deceive the market. This artificially inflated the price of LKQ common stock and operated as a fraud or deceit on the Class. Later, when defendants’ prior misrepresentations and fraudulent conduct were disclosed to the market, the price of LKQ common stock declined significantly as the prior artificial inflation came out over time. As a result of their purchases of LKQ common stock during the class period, members of the class suffered economic loss.
DEADLINE: June 22, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/lkq-corporation-loss-submission-form/?id=188966&from=3
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of LKQ during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is June 22, 2026. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against LKQ Corporation (NASDAQ: LKQ) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired LKQ securities between February 27, 2023 and July 23, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/LKQ.
LKQ Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
(1) LKQ’s acquisition and integration of FinishMaster did not present the “minimal integration risk” Defendants had represented;
(2) the acquisition was not the “compelling strategic fit” purported to enhance LKQ’s business and drive profitable growth;
(3) FinishMaster did not meaningfully improve LKQ’s scale or product mix to compete in the North American automotive paint segment as touted; and
(4) as a result, Defendants’ public statements regarding the acquisition, integration prospects, and related benefits were materially false and misleading at all relevant times.
What's Next for LKQ Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/LKQ. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in LKQ you have until June 22, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to LKQ Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for LKQ Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
LOS ANGELES, June 22, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected].
LKQ Corporation (NASDAQ: LKQ)
Class Period: February 27, 2023 – July 23, 2025
Lead Plaintiff Deadline: June 22, 2026
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) FinishMaster was losing major customers from the time the acquisition was announced and its business could not sustain, let alone grow, LKQ’s eroding market share; (2) such risks regarding the Uni-Select acquisition and FinishMaster integration had already materialized and were negatively impacting LKQ’s operational and financial performance; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you are a LKQ shareholder who suffered a loss, click here to participate.
Regencell Bioscience Holdings Limited (NASDAQ: RGC)
Class Period: October 28, 2024 – October 31, 2025
Lead Plaintiff Deadline: June 23, 2026
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Regencell was vulnerable and/or subject to market manipulation; (2) the resulting volatility in the market for the Company’s ordinary shares exposed Regencell’s investors to significant financial risk; (3) all the foregoing subjected Regencell to a heightened risk of regulatory and/or governmental scrutiny and enforcement action, as well as significant legal, monetary, and reputational harm; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you are a Regencell shareholder who suffered a loss, click here to participate.
Globant S.A. (NYSE: GLOB)
Class Period: February 15, 2024 – August 14, 2025
Lead Plaintiff Deadline: June 23, 2026
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Globant was facing decreasing demand across Latin America and had frozen wages in both Argentina and Mexico in late 2023 and Latin American clients were reducing and cancelling their projects with the Company; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you are a Globant shareholder who suffered a loss, click here to participate.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007 [email protected]
www.frankcruzlaw.com
NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against LKQ Corporation (NASDAQ: LKQ) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired LKQ securities between February 27, 2023 and July 23, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/LKQ.
LKQ Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
(1) LKQ’s acquisition and integration of FinishMaster did not present the “minimal integration risk” Defendants had represented;
(2) the acquisition was not the “compelling strategic fit” purported to enhance LKQ’s business and drive profitable growth;
(3) FinishMaster did not meaningfully improve LKQ’s scale or product mix to compete in the North American automotive paint segment as touted; and
(4) as a result, Defendants’ public statements regarding the acquisition, integration prospects, and related benefits were materially false and misleading at all relevant times.
What's Next for LKQ Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/LKQ. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in LKQ you have until June 22, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to LKQ Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for LKQ Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
Southern Co. (SO - Free Report) closed the most recent trading day at $92.53, moving -1.89% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 1.22%. On the other hand, the Dow registered a loss of 0.98%, and the technology-centric Nasdaq decreased by 1.35%.
Heading into today, shares of the power company had gained 0.18% over the past month, lagging the Utilities sector's gain of 1.96% and the S&P 500's gain of 1.56%.
Market participants will be closely following the financial results of Southern Co. in its upcoming release. The company is forecasted to report an EPS of $1.01, showcasing a 10.99% upward movement from the corresponding quarter of the prior year. Meanwhile, the latest consensus estimate predicts the revenue to be $7.39 billion, indicating a 5.94% increase compared to the same quarter of the previous year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $4.58 per share and a revenue of $31.36 billion, indicating changes of +6.51% and +6.1%, respectively, from the former year.
Investors should also take note of any recent adjustments to analyst estimates for Southern Co. These revisions help to show the ever-changing nature of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.03% increase. Southern Co. is currently a Zacks Rank #3 (Hold).
With respect to valuation, Southern Co. is currently being traded at a Forward P/E ratio of 20.6. For comparison, its industry has an average Forward P/E of 18.17, which means Southern Co. is trading at a premium to the group.
One should further note that SO currently holds a PEG ratio of 2.85. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Utility - Electric Power industry had an average PEG ratio of 2.7 as trading concluded yesterday.
The Utility - Electric Power industry is part of the Utilities sector. With its current Zacks Industry Rank of 107, this industry ranks in the top 44% of all industries, numbering over 250.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - Southern Silver Exploration Corp. (TSXV: SSV) (the "Company" or "Southern Silver") reports that crews have mobilized in preparation for further drilling on the Cerro Las Minitas Project, Durango, Mexico.
The upcoming exploration program follows 2025-26 drilling on the property which successfully delineated mineralization at the Puro Corazon target and returned multiple intercepts of high-grade, polymetallic Ag-Pb-Zn mineralization. Mineralization was extended laterally for the full 400 metres strike-length of the Puro Corazon claim and to depths of up to 450 metres below surface.
The current program will build upon this earlier work and includes up to 12,500 metres of definition drilling designed to increase the classification confidence of a subset of near-surface, high-grade mineralization in the Puro Corazon target and forms part a larger program to assess, geologically and spatially, the historic Puro Corazon claim and to incorporate the underlying mineralization into the larger CLM district.
Other work on the CLM Project includes an update of the mineral resource estimate based on the most recent drilling at Puro Corazon, scheduled for Q3 2026 and the advancement of several engineering opportunities identified in the 2024 preliminary economic assessment ("PEA") of the project.
As currently modelled, the Cerro Las Minitas project features a large-scale underground mining operation with robust project economics and high gross revenues in a well located and mining friendly jurisdiction in southeast Durango, Mexico. For more information on the details of the current economic assessment of the Cerro Las Minitas project please refer to Southern Silver's news release dated June 10, 2024.
Next Steps
The Company is planning to incorporate the results of the 2025-26 Puro Corazon drill program into the much larger Cerro Las Minitas project which is expected to significantly enhance both the project economics and the mine plan. Final assays from the 2025-26 drilling have been received. Work through Q3-Q4 2026 will include:
an update of the Mineral Resource Estimate of the Cerro Las Minitas project; followed by an update of the Preliminary economic Assessment ("PEA") of the project in accordance with the provisions of National Instrument 43-101 and continue to advance baseline data collection and permit readiness reviewThe Company reports that, subsequent to acquisition of the Puro Corazon claim and to the July 2024 PEA, work on the Cerro Las Minitas project continues advancing numerous upside economic and mine development opportunities while also derisking and advancing the project with the commencement of baseline data collection, hydrology, geotechnical, archaeological and land surveys and studies.
About Southern Silver Exploration Corp.
Southern Silver Exploration Corp. is an exploration and development company with a focus on the discovery of world-class mineral deposits either directly or through joint-venture relationships in mineral properties in major jurisdictions. Our specific emphasis is the 100% owned Cerro Las Minitas silver-lead-zinc project located in the heart of Mexico's Faja de Plata, which hosts multiple world-class mineral deposits such as Penasquito, Los Gatos, San Martin, Naica and Pitarrilla. We have assembled a team of highly experienced technical, operational and transactional professionals to support our exploration efforts in developing the Cerro Las Minitas project into a premier, high-grade, silver-lead-zinc mine. Located in the same State as the Cerro Las Minitas property is the newly acquired Nazas, gold-silver property. Our property portfolio also includes the Oro porphyry copper-gold project and the Hermanas gold-silver vein project where permitting applications for the conduct of a drill program is underway, both located in southern New Mexico, USA.
Robert Macdonald, MSc. P.Geo, is an officer of Southern Silver Exploration Corp. and is a Qualified Person as defined by National Instrument 43-101. Mr. Macdonald supervised directly the collection of the data from the CLM project that is reported in this disclosure. He is responsible for and approves the presentation of the technical information in this news release.
On behalf of the Board of Directors
"Lawrence Page"
Lawrence Page, K.C.
President & Director, Southern Silver Exploration Corp.
For further information, please visit Southern Silver's website at southernsilverexploration.com or contact us at 604.641.2759 or by email at [email protected].
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking statements. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. Forward-looking statements in this news release include plans to advance and develop the CLM property including updating the Mineral Resource Estimate followed by an update of the PEA. These statements are based on a number of assumptions, including, but not limited to, general economic conditions, interest rates, commodity markets, regulatory and governmental approvals for the Company's projects, and the availability of financing for the Company's development projects on reasonable terms. Factors that could cause actual results to differ materially from those in forward-looking statements include the timing and receipt of government and regulatory approvals, and continued availability of capital and financing and general economic, market or business conditions.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301977
Source: Southern Silver Exploration Corp.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
, /PRNewswire/ -- Southern California Gas Co. (SoCalGas), a subsidiary of Sempra (NYSE: SRE), today announced that employees dedicated more than 1,100 volunteer hours in May—equivalent to over 27 full-time workweeks—through its Glad to be of service® initiative. Spanning 38 cities and nine counties, these efforts strengthened local communities and helped connect families to resources that can reduce everyday costs—including food assistance, clothing and workforce programs.
Through 19 volunteer events and ongoing individual efforts, over 200 employees supported 57 nonprofit organizations, focusing on critical needs such as food access, housing support, workforce readiness and services for seniors and veterans.
"At SoCalGas, we know many families are feeling financial pressure right now," said Clay Faber, director of community and stakeholder engagement at SoCalGas. "That's why our employees volunteer alongside local organizations to help expand access to food, housing support and other essentials that can make a real difference."
"Collaborations like this are essential to meeting the growing need we see across Southern California," said Lt. Colonel Mike Dickinson, The Salvation Army Southern California Division. "SoCalGas employees show up ready to work and make a real difference—helping us expand access to critical resources for families who need it most."
Employees supported the Los Angeles Regional Food Bank, Orange County Food Bank, FIND Food Bank, Venice Family Clinic, LA Family Housing, The Salvation Army, Junior Achievement SoCal and many others, through initiatives focused on helping meet essential needs, including:
Food distribution and insecurity relief, expanding access to no-cost groceries Housing and homelessness support, helping individuals and families access stable, supportive housing Workforce development and financial readiness, including financial literacy programs and professional clothing donations Support for seniors and vulnerable populations, providing essential services and community connection Community resilience and recovery efforts, strengthening local economic stability Additional activities included clothing and diaper drives, youth mentorship, community cleanups and support for students, low-income households, veterans, seniors and individuals experiencing homelessness.
These volunteer efforts complement SoCalGas's broader commitment to helping customers manage energy costs through assistance programs, energy efficiency resources and community projects. They also complement employees' day-to-day work, providing additional ways to support the communities we serve. Volunteer service is ongoing throughout the year, reflecting the company's continued focus on delivering value to customers and strengthening the communities it serves. For more information, visit socalgas.com/about-us/our-impact.
About SoCalGas
SoCalGas is the largest gas distribution utility in the United States, serving more than 21 million consumers across approximately 24,000 square miles of Central and Southern California. Our mission is: Safe, Reliable, and Affordable energy delivery today. Ready for tomorrow. SoCalGas is a recognized leader in the energy industry and has been named Corporate Member of the Year by the Los Angeles Chamber of Commerce for its volunteer leadership in the communities it serves. SoCalGas is a subsidiary of Sempra (NYSE: SRE), a leading U.S. utility holding company. For more information, visit SoCalGas.com/newsroom or connect with SoCalGas on social media @SoCalGas.
SHENZHEN, CHINA, June 22, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of the People’s Republic of China (“NMPA”) and the drug registration certificate was obtained on 22 June 2026. The Product is indicated for passive immunization in adults following rabies virus exposure.
Silevimig Injection is the world’s first fully human bispecific antibody targeting dual epitopes of the rabies virus (“RABV”), which is consistent with the recommendations of the World Health Organization (“WHO”) for a “cocktail” therapeutic paradigm. It demonstrates broad neutralization, which can effectively neutralize different viral strains or genotypes of RABV, providing immediate protection. Moreover, it is the passive immunization product with the smallest dose for rabies, resulting in less injection volume and easier administration, which can effectively reduce patient pain and improve compliance. In addition, the Product can be manufactured at scale with standardized processes and controlled production cost, and also carries no risks of blood-borne infections, low immunogenicity, and minimal interference with vaccine-induced active immunization. The market for rabies passive immunization is substantial, yet existing passive immunization products are constrained by low market penetration and limitations in safety and accessibility. The approval of the Product will provide a new treatment option for patients requiring urgent post-exposure management against rabies in China.
The approval of Silevimig Injection expands the Group’s commercialized innovative drug portfolio to 8 products, with 6 more innovative drugs under marketing review and approximately 20 projects advancing clinical development, further strengthening a tiered innovation pipeline. As of now, CMS’s innovation transformation strategy has fully entered the value-harvesting phase. Leveraging the Group’s existing expert network and market resources, the commercialization rollout of Silevimig Injection is expected to proceed steadily providing sustained momentum to the Group’s performance growth.
About Rabies
Rabies is an acute zoonotic disease caused by RABV, clinically characterized by aerophobia, hydrophobia, pharyngeal muscle spasms, and progressive paralysis[1], with a case-fatality rate approaching 100%. At present, there is no proven treatment for rabies once clinical symptoms appear. Standardized post-exposure management, comprising wound care, vaccination, and passive immunization administered as needed, remains the most effective strategy[2]. As vaccine-induced antibodies require 1-2 weeks after the first dose of vaccine injection to reach protective levels, passive immunization provides immediate coverage[1]. According to the National Technical Guidelines for the Rabies Exposure Prophylaxis (2023 Edition), patients with Category III exposure and those with Category II exposure involving severe immunodeficiency should receive passive immunization at the same time as the first dose of rabies vaccine[3]. In China, more than 40 million people are exposed to rabies annually, of whom approximately 40% fall under Category III exposure[1]. However, due to factors such as limited awareness, high cost, and restricted accessibility, only about 15% of Category III cases receive passive immunization[1]. Currently, the primary approved passive immunization option in China is human rabies immune globulin (“HRIG”). However, HRIG must be sourced from healthy donors, making it difficult and costly to obtain. Furthermore, it carries potential risks of blood-borne infections. This has led to a low penetration rate of passive immunization products in China.
More information about Silevimig Injection
Silevimig Injection is a recombinant, fully human bispecific antibody against rabies virus. It targets the viral envelope glycoprotein (G protein) of RABV and blocks its interaction with host receptors by binding to epitopes I and III. Through this mechanism, Silevimig Injection specifically neutralizes the RABV prior to the establishment of full protection by active rabies vaccination.
In a Phase III clinical trial in adults, the Product met its primary efficacy endpoint, demonstrating non-inferior protective efficacy compared with HRIG, the currently most used passive immunization product in China. The study confirmed that the Product provides immediate protection during the early stages of rabies virus exposure without compromising the active immune response induced by vaccination. In addition, a Phase III clinical trial in children and adolescents aged 2 to <18 years is currently ongoing in China. The Product has been granted a patent in China.
In September 2025, the Group through subsidiaries of the Company entered into an Exclusive Collaboration Agreement (the “Agreement”) with Chongqing Genrix Biopharmaceutical Co., Ltd.. In accordance with the Agreement, the Group has obtained exclusive commercialization rights for the Product in mainland China and exclusive licensing rights for the rest of the Asia-Pacific region, the Middle East and North Africa. The collaboration term extends until ten years after the Product receives the marketing approval in Mainland China (the “Initial Term for the Product”). Unless terminated or dissolved under the terms set forth in the Agreement, the Agreement will automatically renew for successive ten-year periods upon expiration of the Initial Term for the Product.
About CMS
CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.
CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.
CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.
Reference:
1. Chinese Center for Disease Control and Prevention. Technical Guidelines for Human Rabies Prevention and Control (2016). https://www.chinacdc.cn/jkyj/crb2/yl/kqb/jswj_kqb/202409/P020240906525420231910.pdf
2. Yin Wenwu, Wang Chuanlin, et al. Expert consensus on rabies exposure prophylaxis[J]. Chinese Journal of Preventive Medicine, 2019,53(7): 668-679. DOI:10.3760/cma.j.issn.0253-9624.2019.07.004
3. Chinese Center for Disease Control and Prevention. The National Regulation for the Rabies Exposure Prophylaxis (2023 Edition). https://www.chinacdc.cn/jkyj/crb2/yl/kqb/jswj_kqb/202409/P020240906525421817465.pdf
CMS Disclaimer and Forward-Looking Statements
This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.
This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
Ho Chi Minh City, Vietnam, June 19, 2026 (GLOBE NEWSWIRE) -- KiN Hotel Thi Sach Edition is pleased to announce today that it has been recognized in Tripadvisor's Travelers' Choice® Awards for 2026. Tripadvisor’s Travelers’ Choice Award winners are among the top 10% of listings around the world on Tripadvisor.
KiN Hotel Thi Sach Edition Recognized as a Top-Rated Hotel in Ho Chi Minh
As the world’s largest travel guidance platform, Tripadvisor has unparalleled authority with travelers and diners. This award is based on genuine feedback from anyone in the community who has visited and left an authentic, first-hand review on Tripadvisor over a 12-month period, making it a valuable and trustworthy designation of travelers’ favorites.
"Receiving the Tripadvisor Travelers' Choice Award for 2026 is a true reflection of the people behind KiN Hotel Thi Sach Edition — our team, our guests, and our community. By combining movement, culture, and meaningful partnerships, we hope to inspire the community to connect and experience Ho Chi Minh City in a way that is authentic and unforgettable. This award affirms that what we are building resonates, and we look forward to continuing this journey with our community." - Benny, Co-Founder & CBO, KiN Hotel Group
“Congratulations to KiN Hotel Thi Sach Edition on its recognition in Tripadvisor’s Travelers’ Choice Awards for 2026,” said Matt Dacey, Chief Marketing Officer, Tripadvisor. “Ranking among the top percentage of businesses globally means you have made such a memorable impact on your visitors that many of them took time to go online and leave a glowing review about their experience. We hope this recognition continues to drive business to you in 2026 and beyond.”
Check out all the reviews and discover more about KiN Hotel Thi Sach Edition here.
About KiN Group
KiN Group is a Singapore-headquartered integrated lifestyle hospitality company building next-generation urban experiences across Southeast Asia. Rooted in the philosophy of the Warmth of Kinship, the Group owns, operates, and grows a portfolio of branded hospitality destinations that combine thoughtful design, technology integration, and community-driven experiences for the modern traveller.
The Group's ecosystem spans four pillars: Hospitality Operations (KiN Hotel, KiN Hotel Edition, NiK Hotel, KiN Wander), Real Estate and Business Solution (Crestbrick), Brand Amplification (KiN Circle), and Technology (KiNex). With over 30 hotels across Vietnam and an expanding footprint into Malaysia, Singapore, and China, KiN Group is targeting 13,000 rooms by 2029.
Headquartered in Singapore. Rooted in Ho Chi Minh City. Growing across Southeast Asia.
About Tripadvisor
Tripadvisor, the world's largest travel guidance platform, helps millions of people each month become better travelers, from planning to booking to taking a trip. Travelers across the globe use the Tripadvisor site and app to discover where to stay, what to do and where to eat based on guidance from those who have been there before. With more than 1 billion reviews and contributions, travelers turn to Tripadvisor to find deals on accommodations, book experiences, reserve tables at delicious restaurants and discover great places nearby.
Planned transition supports continued growth and strong leadership continuity June 19, 2026 13:00 ET | Source: SPX Technologies
CHARLOTTE, N.C., June 19, 2026 (GLOBE NEWSWIRE) -- SPX Technologies (NYSE: SPXC) (“SPX” or the “Company”) today announced a planned leadership transition within its Detection & Measurement (D&M) segment.
After an outstanding career with SPX, John Swann has announced plans to retire in January 2027. Since joining the company in 2004, Swann has played a pivotal role in shaping the business—driving growth, building high-performing teams, and delivering strong results across multiple areas of the portfolio, most recently as leader of the D&M segment.
As part of a thoughtful and planned succession, Eric Kaled will succeed Swann as leader of the D&M segment, effective August 31, 2026.
“On behalf of the Board and the entire SPX leadership team, I want to thank John for his many years of outstanding service and leadership,” said Gene Lowe, President and Chief Executive Officer of SPX Technologies. “During his tenure, John played a central role in scaling our businesses into larger, stronger and more profitable growth platforms. His focus on developing high-performing teams, disciplined approach to strategy and execution and ability to identify and integrate strategic acquisitions have created lasting value for our customers, employees and shareholders. As John transitions his role, I have great confidence in Eric and the D&M leadership team, and I believe the segment is very well positioned to continue its strong momentum.”
Kaled brings a strong track record of performance and leadership at SPX. Since joining the company in 2019, he has strengthened the Transportation and Communications Technologies platforms to grow financial performance and stability through multiple large-scale contract wins and the introduction of advanced customer solutions, while enhancing product innovation and operational execution. His deep understanding of the business, combined with his strategic mindset and operational leadership, position him well to lead the D&M segment into its next phase of growth.
Following the transition, Swann will remain with SPX through the end of the year to support key strategic growth initiatives and ensure a smooth leadership handoff.
About SPX Technologies
SPX Technologies is a supplier of highly engineered products and technologies, holding leadership positions in HVAC and detection and measurement markets. Based in Charlotte, North Carolina, SPX Technologies has approximately 5,300 employees in more than 16 countries. For more information, please visit www.spx.com.
The Construction group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has SPX Technologies (SPXC - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Construction peers, we might be able to answer that question.
SPX Technologies is a member of our Construction group, which includes 88 different companies and currently sits at #16 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. SPX Technologies is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for SPXC's full-year earnings has moved 2.4% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that SPXC has returned about 21.5% since the start of the calendar year. Meanwhile, stocks in the Construction group have gained about 17% on average. This means that SPX Technologies is performing better than its sector in terms of year-to-date returns.
Another Construction stock, which has outperformed the sector so far this year, is Simpson Manufacturing (SSD - Free Report) . The stock has returned 24% year-to-date.
For Simpson Manufacturing, the consensus EPS estimate for the current year has increased 2.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, SPX Technologies belongs to the Building Products - Air Conditioner and Heating industry, a group that includes 7 individual stocks and currently sits at #40 in the Zacks Industry Rank. This group has gained an average of 46.9% so far this year, so SPXC is slightly underperforming its industry in this area.
Simpson Manufacturing, however, belongs to the Building Products - Miscellaneous industry. Currently, this 33-stock industry is ranked #200. The industry has moved +5.3% so far this year.
SPX Technologies and Simpson Manufacturing could continue their solid performance, so investors interested in Construction stocks should continue to pay close attention to these stocks.
Reaffirms Commitment to Superior Offer That Includes Full Option to Elect $12.50 Per Share in Cash
TWO Attempts to Force Inferior Deal While UWMC is Ready and Willing to Deliver Superior Offer
Urges TWO Stockholders to Hold the Line at June 23 Special Meeting and Demand Board Open True, Good-Faith Engagement with UWMC
PONTIAC, Mich. & NEW YORK--(BUSINESS WIRE)--UWM Holdings Corporation (“UWMC” or the “Company”) (NYSE: UWMC), today reaffirmed its commitment to acquire Two Harbors Investment Corp. (“Two Harbors” or “TWO”) (NYSE: TWO) and issued a statement regarding the upcoming special meeting on June 23 to vote on TWO’s proposed merger with CrossCountry Mortgage, LLC ("CrossCountry" or "CCM"), following the third adjournment.
UWMC issued the following statement:
“TWO stockholders have sent a clear message over and over again: they do not support the inferior CCM transaction or the TWO Board’s repeated adjournments – and we urge them to continue to reject CCM’s inferior proposal. It’s high time that the TWO Board respect the will of their stockholders.
“In stark contrast, UWMC’s proposal offers both higher value and stockholder choice through stock consideration or an election to receive $12.50 per share in cash with full financing. That optionality is a clear benefit to stockholders, not a flaw. UWMC remains committed to its superior proposal, to reaching a transaction that is best for UWMC and for TWO stockholders, to delivering a superior offer and finalizing an agreement quickly if the TWO Board will finally do the right thing and engage in good faith.
“Stockholders should not be forced into the inferior CCM deal because TWO’s management thinks it is better for them personally. It is ironic that the TWO Board bemoans the decline of its stock price, when they have a path to maximizing value for all TWO stockholders: true engagement with UWMC. TWO stockholders should continue to vote AGAINST the CCM merger and demand that the TWO Board engage with UWMC in an open, unrestricted and good-faith manner.”
TWO stockholders should remember:
UWMC’s proposal provides higher value. UWMC’s proposal provides stockholders the option to elect $12.50 per share in cash, compared to CCM’s “best and final” $12.00 per share agreement. UWMC’s proposal provides stockholder choice. TWO stockholders can receive 2.3328 shares of UWMC stock at closing per share of TWO, preserving potential upside in the combined company. The TWO Board has categorically ruled out any formulation that includes stock, removing this optionality for stockholders. UWMC remains ready for true, good-faith engagement. TWO’s short-lived attempt at engagement was a smokescreen, given the arbitrary deadlines, restricted participation, and harsh preconditions that limited constructive discussion. UWMC is prepared to continue discussing terms, including alternatives around the default election mechanism and other adjustments to the merger consideration, if TWO will finally conduct open negotiations. Independent proxy advisors have universally recommended AGAINST the CCM transaction. ISS, Glass Lewis and Egan-Jones have all recommended that TWO stockholders vote AGAINST the CCM transaction, citing concerns with the TWO Board’s process and the availability of UWMC’s superior offer. Voting AGAINST the CCM transaction is the only way to maintain a path to maximum value. Without full engagement with UWMC, TWO stockholders can never be certain that their Board has delivered maximum value for their holdings. Keeping pressure on the Board by voting AGAINST the inferior CCM transaction is the only path to asserting stockholders’ rights. VOTE AGAINST THE PROPOSED CCM MERGER ON THE BLUE PROXY CARD TODAY!
UWMC encourages all TWO stockholders to VOTE AGAINST Two Harbors’ CCM Merger Proposal, AGAINST the Non-Binding Compensation Advisory Proposal and AGAINST the Adjournment Proposal according to the instructions on UWMC’s BLUE Proxy Card today to preserve the opportunity to achieve greater value by engaging with UWMC’s superior proposal.
If you have any questions or require assistance with voting your shares, please contact our proxy solicitor, Okapi Partners, by calling (844) 343-2621 (Toll Free for stockholders) or (212) 297-0720 (for Banks and Brokers), or by email at [email protected].
IT IS NOT TOO LATE TO CHANGE YOUR VOTE.
ONLY YOUR LAST SUBMITTED AND RECEIVED VOTE WILL COUNT AT THE MEETING.
YOUR VOTE IS IMPORTANT, NO MATTER HOW MANY SHARES YOU OWN!
About UWM Holdings Corporation and United Wholesale Mortgage
Headquartered in Pontiac, Michigan, UWM Holdings Corporation (UWMC) is the publicly traded indirect parent of United Wholesale Mortgage, LLC (“UWM”). UWM is the nation’s largest home mortgage lender, despite exclusively originating mortgage loans through the wholesale channel. UWM has been the largest wholesale mortgage lender for 11 consecutive years and is also the largest purchase lender in the nation. With a culture of continuous innovation of technology and enhanced client experience, UWM leads the market by building upon its proprietary and exclusively licensed technology platforms, superior service and focused partnership with the independent mortgage broker community. UWM originates primarily conforming and government loans across all 50 states and the District of Columbia. For more information, visit uwm.com or call 800-981-8898. NMLS #3038.
This communication includes forward-looking statements. These forward-looking statements are generally identified using words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict” and similar words indicating that these reflect our views with respect to future events. Forward-looking statements in this communication include statements regarding our expectations and beliefs related to (i) the timing of the completion of any proposed transaction; (ii) the ability of the parties to complete any proposed transaction; and (iii) the benefits of a proposed transaction. These statements are based on management’s current expectations, but are subject to risks and uncertainties, many of which are outside of our control, and could cause future events or results to materially differ from those stated or implied in the forward-looking statements, including: (i) that the parties will not agree to pursue a business combination transaction or that the terms of any such transaction will be materially different from those described herein; (ii) the ability of the parties to satisfy the conditions to any proposed transaction, including obtaining stockholder approval and regulatory approval, on a timely basis or at all; (iii) the ability to obtain synergies and benefits of any proposed transaction; (iv) UWM’s ability to successfully implement strategic decisions and product launches; (iv) UWM’s dependence on macroeconomic and U.S. residential real estate market conditions, including changes in U.S. monetary policies, more specifically caused by the Presidential Administration that affect interest rates and inflation; (vi) UWM’s reliance on its warehouse and MSR facilities and the risk of a decrease in the value of the collateral underlying certain of its facilities causing an unanticipated margin call; (vii) UWM’s ability to sell loans in the secondary market; (viii) UWM’s dependence on the government-sponsored entities such as Fannie Mae and Freddie Mac; (ix) changes in the GSEs, FHA, USDA and VA guidelines or GSE and Ginnie Mae guarantees; (x) our ability to consummate the merger with Two Harbors and achieve the anticipated benefits; (xi) our ability to comply with all rules and regulations in connection with the launch of our internal servicing and the new risks that may be presented as a result of the transition; (xii) UWM’s dependence on Independent Mortgage Advisors to originate mortgage loans; (xiii) the risk that an increase in the value of the MBS UWM sells in forward markets to hedge its pipeline may result in an unanticipated margin call; (xiv) UWM’s inability to continue to grow, or to effectively manage the growth of its loan origination volume; (xv) UWM’s ability to continue to attract and retain its broker relationships; (xvi) UWM’s ability to implement technological innovation, such as AI in our operations; (xvii) the occurrence of a data breach or other failure of UWM’s cybersecurity or information security systems; (xviii) reliance on third-party software and services; the occurrence of data breaches or other cybersecurity failures at our third-party sub-servicers or other third-party vendors; (xix) UWM’s ability to continue to comply with the complex state and federal laws, regulations or practices applicable to mortgage loan origination and servicing in general; and (xx) other risks and uncertainties indicated from time to time in our filings with the Securities and Exchange Commission (the “SEC”) including those under “Risk Factors” therein. We wish to caution readers that certain important factors may have affected and could in the future affect our results and could cause actual results for subsequent periods to differ materially from those expressed in any forward-looking statement made by or on behalf of us. We undertake no obligation to update forward-looking statements to reflect events or circumstances after the date hereof.
No Offer or Solicitation
This communication is for informational purposes only and is not intended to, and shall not, constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
Additional Information
This communication relates to a proposal that UWMC has made to the Two Harbors Board for a business combination transaction with Two Harbors. In furtherance of this proposal and subject to future developments, UWMC filed a definitive proxy statement on Schedule 14A on May 14, 2026 (the “Proxy Statement”) with the SEC in order to solicit proxies against the Proposed CCM Merger and other proposals to be voted on by TWO stockholders at the special meeting of TWO stockholders to be held to approve the Proposed CCM Merger. UWMC may file amendments or supplements to the Proxy Statement and one or more registration statements, proxy statements, tender or exchange offers or other documents with the SEC. This communication is not a substitute for any proxy statement, registration statement, tender or exchange offer document, prospectus or other document UWMC and/or Two Harbors may file with the SEC in connection with a proposed transaction.
INVESTORS AND SECURITYHOLDERS OF UWMC AND TWO HARBORS ARE URGED TO READ THE PROXY STATEMENT, ANY ADDITIONAL MATERIALS UWMC MAY FILE WITH RESPECT TO THE BUSINESS COMBINATION TRANSACTION, INCLUDING ANY REGISTRATION STATEMENT, TENDER OR EXCHANGE OFFER DOCUMENT, PROSPECTUS, AND ANY OTHER RELEVANT DOCUMENTS IF AND WHEN FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY, WHEN THEY ARE AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT UWMC, TWO HARBORS, A PROPOSED TRANSACTION AND RELATED MATTERS. Investors and securityholders of UWMC and Two Harbors will be able to obtain copies of these documents if and when they become available, as well as other filings with the SEC that will be incorporated by reference into such documents, containing information about UWMC and Two Harbors, without charge, at the SEC’s website (http://www.sec.gov). Copies of the documents filed with the SEC by UWMC will be available free of charge under the SEC Filings heading of the Investor Relations section of UWMC’s website at https://investors.uwm.com.
Participants in the Solicitation
UWMC and its respective directors and executive officers and other members of management and employees may be deemed to be participants in any solicitation of proxies from Two Harbors stockholders in respect of a solicitation and proposed transaction under the rules of the SEC. Information regarding UWMC’s directors and executive officers is available in UWMC’s Annual Report on Form 10-K for the year ended December 31, 2025, and UWMC’s proxy statement, dated April 24, 2026, for its 2026 annual meeting of stockholders (the “UWMC 2026 Proxy”), which can be obtained free of charge through the website maintained by the SEC at http://www.sec.gov. Please refer to the sections captioned “Compensation Discussion and Analysis”, “Executive Compensation”, “Stock Ownership” and “Proposal 3 – Advisory Vote on Executive Officer Compensation” in the UWMC 2026 Proxy. Any changes in the holdings of UWMC’s securities by UWMC’s directors or executive officers from the amounts described in the UWMC 2026 Proxy have been reflected in Statements of Change in Ownership on Form 4 filed with the SEC subsequent to the filing date of the UWMC 2026 Proxy and are available at the SEC’s website at www.sec.gov.
I maintain a buy rating on HEICO Corporation as fundamentals strengthen, despite a premium valuation. FSG segment delivers 21% sales growth and margin expansion, driven by resilient global aviation aftermarket demand. ETG segment accelerates with 34% sales growth and margin gains, supported by robust aerospace and defense end markets.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at Novanta (NOVT - Free Report) , a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Novanta currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market? In order to see if NOVT is a promising momentum pick, let's examine some Momentum Style elements to see if this photonic and motion control components maker holds up.
Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.
For NOVT, shares are up 2.71% over the past week while the Zacks Electronics - Miscellaneous Components industry is flat over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 5.13% compares favorably with the industry's 8.05% performance as well.
While any stock can see its price increase, it takes a real winner to consistently beat the market. That is why looking at longer term price metrics -- such as performance over the past three months or year -- can be useful as well. Shares of Novanta have increased 29.86% over the past quarter, and have gained 26.85% in the last year. In comparison, the S&P 500 has only moved 12.48% and 26.22%, respectively.
Investors should also pay attention to NOVT's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. NOVT is currently averaging 474,067 shares for the last 20 days.
Earnings OutlookThe Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with NOVT.
Over the past two months, 2 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost NOVT's consensus estimate, increasing from $3.54 to $3.59 in the past 60 days. Looking at the next fiscal year, 1 estimate has moved upwards while there have been no downward revisions in the same time period.
Bottom LineGiven these factors, it shouldn't be surprising that NOVT is a #2 (Buy) stock and boasts a Momentum Score of B. If you're looking for a fresh pick that's set to soar in the near-term, make sure to keep Novanta on your short list.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. “We are pleased to welcome a talented and experienced financial executive of John's caliber to CONMED,” said Patrick J. Beyer, CONMED's President and Chief Executive Officer. “John brings deep healthcare and.
, /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Olin Corporation (NYSE: OLN) related to its merger with Huntsman Corporation. Upon closing of the proposed transaction, Olin shareholders will own approximately 54.5% of the combined company. Is it a fair deal?
Click here for more info https://monteverdelaw.com/case/olin-corporation/https://monteverdelaw.com/case/psb-holdings-inc/https://monteverdelaw.com/case/xoma-royalty-corporation/https://monteverdelaw.com/case/globalstar-inc-2/https://monteverdelaw.com/case/calisa-acquisition-corp/https://monteverdelaw.com/?post_type=case&p=12170&preview=true. It is free and there is no cost or obligation to you.
NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask:
Do you file class actions and go to Court? When was the last time you recovered money for shareholders? What cases did you recover money in and how much? About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No one is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341
Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
From a technical perspective, Microchip Technology (MCHP - Free Report) is looking like an interesting pick, as it just reached a key level of support. MCHP recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
The 20-day simple moving average is a well-liked trading tool because it provides a look back at a stock's price over a 20-day period. Additionally, short-term traders find this SMA very beneficial, as it smooths out short-term price trends and shows more trend reversal signals than longer-term moving averages.
The 20-day moving average can show signals that are similar to other SMAs as well. If a stock's price is moving above the 20-day, the trend is considered positive. When the price falls below the moving average, it can signal a downward trend.
Over the past four weeks, MCHP has gained 9.5%. The company is currently ranked a Zacks Rank #1 (Strong Buy), another strong indication the stock could move even higher.
The bullish case solidifies once investors consider MCHP's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 8 higher, while the consensus estimate has increased too.
Given this move in earnings estimate revisions and the positive technical factor, investors may want to keep their eye on MCHP for more gains in the near future.
Investors interested in Computer and Technology stocks should always be looking to find the best-performing companies in the group. Has Microchip Technology (MCHP - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Computer and Technology peers, we might be able to answer that question.
Microchip Technology is one of 592 companies in the Computer and Technology group. The Computer and Technology group currently sits at #1 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Microchip Technology is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for MCHP's full-year earnings has moved 23.4% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that MCHP has returned about 56.6% since the start of the calendar year. Meanwhile, stocks in the Computer and Technology group have gained about 20% on average. This means that Microchip Technology is outperforming the sector as a whole this year.
One other Computer and Technology stock that has outperformed the sector so far this year is Advanced Energy Industries (AEIS - Free Report) . The stock is up 78% year-to-date.
The consensus estimate for Advanced Energy Industries' current year EPS has increased 9.5% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Microchip Technology belongs to the Semiconductor - Analog and Mixed industry, a group that includes 10 individual stocks and currently sits at #5 in the Zacks Industry Rank. On average, this group has gained an average of 69.7% so far this year, meaning that MCHP is slightly underperforming its industry in terms of year-to-date returns.
On the other hand, Advanced Energy Industries belongs to the Semiconductor Equipment - Wafer Fabrication industry. This 2-stock industry is currently ranked #27. The industry has moved +80.2% year to date.
Microchip Technology and Advanced Energy Industries could continue their solid performance, so investors interested in Computer and Technology stocks should continue to pay close attention to these stocks.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at Microchip Technology (MCHP - Free Report) , which currently has a Momentum Style Score of B. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Microchip Technology currently has a Zacks Rank of #1 (Strong Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market? In order to see if MCHP is a promising momentum pick, let's examine some Momentum Style elements to see if this chipmaker holds up.
A good momentum benchmark for a stock is to look at its short-term price activity, as this can reflect both current interest and if buyers or sellers currently have the upper hand. It's also helpful to compare a security to its industry; this can show investors the best companies in a particular area.
For MCHP, shares are up 7.81% over the past week while the Zacks Semiconductor - Analog and Mixed industry is up 4.23% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 9.51% compares favorably with the industry's 3.76% performance as well.
Considering longer term price metrics, like performance over the last three months or year, can be advantageous as well. Shares of Microchip Technology have increased 55.4% over the past quarter, and have gained 46.68% in the last year. In comparison, the S&P 500 has only moved 13.47% and 26.67%, respectively.
Investors should also pay attention to MCHP's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. MCHP is currently averaging 11,578,530 shares for the last 20 days.
Earnings OutlookThe Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with MCHP.
Over the past two months, 8 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost MCHP's consensus estimate, increasing from $2.57 to $3.03 in the past 60 days. Looking at the next fiscal year, 3 estimates have moved upwards while there have been no downward revisions in the same time period.
Bottom LineTaking into account all of these elements, it should come as no surprise that MCHP is a #1 (Strong Buy) stock with a Momentum Score of B. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Microchip Technology on your short list.
PPL Corporation's recent share weakness raises a key question as data center demand and a $23 billion investment plan meet valuation, debt and ROE concerns.
Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes.This milestone reflects the Company's long-range quality strategy focused on sustained compliance, continuous audit readiness, and operational effectiveness.Through robust governance, quality culture initiatives, workforce development, and digital transformation, Piramal continues to strengthen its position as a reliable global CDMO partner., /PRNewswire/ -- Piramal Pharma Solutions ("PPS"), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), today announced that it completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past fiscal year. The positive outcomes reflect the strength of the Company's long-range quality strategy and its ongoing commitment to scientific excellence and continuous improvement.
PPS's quality strategy combines robust governance, quality culture, workforce development, process harmonization, and digital transformation to support sustained compliance, continuous audit readiness, and operational effectiveness. This approach helps the Company proactively address evolving regulatory expectations while maintaining a high level of readiness across its global development and manufacturing operations.
Key elements of this strategy include a comprehensive quality governance framework, predictive quality tools that help assess site readiness and compliance health, and tailored systems that improve efficiency and reduce the cost of poor quality. PPS's REsolute to SOLVE Deviations (RESOLVE) program drives right-first-time execution in manufacturing and Quality Control (QC) laboratories, helping minimize errors and support timely readiness for regulatory interactions. Core initiatives within the program include concurrent batch record review, site-wide quality ownership, shopfloor quality oversight, and strengthened operational vigilance. As part of its broader approach, the Company has also implemented specialized training programs to enhance audit readiness, regulatory engagement, and decision-making, further strengthening quality capabilities across the organization.
Digital platforms are further strengthening quality processes at PPS by increasing efficiency and transparency across global operations. With eLab, PPS digitizes QC laboratories and automates testing processes, helping reduce errors while improving predictability and turnaround times. Complementing that program is exForms, which digitizes GxP forms to support ALCOA compliance, improve accessibility, accelerate approvals, and reinforce continuous audit readiness. To further these efforts, the Company has adopted iAssist, a validated human-in the-loop AI-enabled tool designed to support the speed and rigor of investigations. The tool helps structure investigation outputs, improve consistency, and reduce manual effort for PPS teams. These additions complement already digitized QMS, LMS and DMS platforms, which have been functional for several years now.
"At Piramal Pharma Solutions, quality is integral to everything we do," said Rashida Najmi, PPS's Chief Quality Officer. "Our focus is on building quality into everyday operations so that audit readiness is sustained, not episodic. That discipline helps us deliver the consistency and reliability our customers expect."
PPS successful regulatory and customer audit track record firmly demonstrates the Company's long-term commitment to quality and further reinforces its ability to consistently deliver safe, effective therapies to patients worldwide.
About Piramal Pharma Solutions
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process and pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products and services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines and gene therapies, made possible through Piramal Pharma Limited's associate company, Yapan Bio Private Limited.
For more information visit: Piramal Pharma Solutions | LinkedIn| Facebook | X
About Piramal Pharma Limited
Piramal Pharma Limited (PPL), (NSE: PPLPHARMA) (BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the Piramal Consumer Healthcare business, selling over-the-counter consumer and wellness products. In addition, one of PPL's associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics / bio-therapeutics and vaccine segments.
For more information, visit: Piramal Pharma | LinkedIn
*Includes one facility via PPL's minority investment in Yapan Bio.
View original content to download multimedia:https://www.prnewswire.com/news-releases/piramal-pharma-solutions-highlights-strong-performance-across-more-than-200-customer-audits-302806206.html
The Federal Reserve indicated the possibility of a rate hike this year after its latest meeting, which could have implications for income-seeking investors.
Given this backdrop, dividend-paying stocks with strong yields and upside potential could help investors earn attractive returns.
Backed by solid research, top Wall Street analysts can provide key insights to pick stocks having the ability to generate compelling capital appreciation and pay consistent dividends, driven by solid fundamentals.
Here are three dividend-paying stocks that are highlighted by Wall Street's top pros, as tracked by TipRanks, a platform that ranks analysts based on their past performance.
Kinetik HoldingsKinetik is a midstream company operating in the Delaware basin. With a quarterly dividend of 81 cents per share (annualized dividend of $3.24 per share), KNTK stock offers a dividend yield of about 7%.
RBC Capital analyst Elvira Scotto reiterated a buy rating on Kinetik stock and increased her price target to $53 from $50, citing expected growth from the KL2 project and sour gas opportunity in New Mexico. Scotto updated her estimates to reflect Kinetik's Q1 2026 results, with adjusted EBITDA beating estimates, driven by improved margins and Gulf Coast marketing gains that offset Waha price-related shut-ins.
The five-star analyst expects the Waha price-related shut-ins to persist until incremental takeaway capacity comes online later this year. Scotto said that Kinetik is well-positioned to capture New Mexico sour gas growth prospects when prices support activity. She sees the Northern Delaware Basin in New Mexico as a major growth opportunity for Kinetik. Scotto highlighted that Kinetik has purpose-built its system for sour gas handling, giving it an edge over new competitors that may face permitting delays of at least three years to build acid gas injection wells.
Additionally, Scotto pointed out Kinetik's attractive capital return framework, which targets a 3.5x to 4.0x leverage ratio, 3% to 5% hike in annual dividend until dividend coverage reaches 1.6x, and opportunistic share buybacks.
"We still view KNTK as a logical takeout candidate for buyers seeking to increase equity NGL barrels and sour gas processing," said Scotto.
Scotto ranks No. 211 among more than 12,300 analysts tracked by TipRanks. Her ratings have been successful 68% of the time, delivering an average return of 16%. See Kinetik Financials on TipRanks.
SLBOilfield services company SLB (SLB), formerly known as Schlumberger, is this week's second dividend pick. The company announced a quarterly cash dividend of nearly 30 cents per share, payable on July 9. At an annualized dividend of $1.18 per share, SLB stock offers a dividend yield of 2.5%.
Recently, Goldman Sachs analyst Neil Mehta reiterated a buy rating on SLB stock with a price target of $63, saying that he believes the company is "positioned to capitalize on long-term opportunities in oilfield activity globally triggered by the ongoing disruptions and shifting supply dynamics in the Middle East."
The five-star analyst expects SLB's dominant position in the international oilfield services market to bolster its earnings power over the long term, supported by increased activity levels over the medium to long term.
Given management's commentary on accelerated exploration activity in regions such as Latin America, Africa and Asia, and his expectation for accelerated final investment decisions in deepwater projects in West Africa, the Gulf of America and Brazil, Mehta expects SLB to benefit from higher services activity needed amid increasing drilling and production.
Furthermore, Mehta expects portfolio diversification from the Digital business and data center growth to drive higher earnings over the long term. Notably, the analyst expects SLB to deliver margins of about 40% in the Digital business this year, with further expansion in the years ahead.
Mehta ranks No. 626 among more than 12,300 analysts tracked by TipRanks. His ratings have been successful 60% of the time, delivering an average return of 10.7%. See SLB AI Stock Analysis on TipRanks.
IBMFinally, moving on to tech giant IBM (IBM). The company is increasingly focusing on quantum computing and artificial intelligence to drive future growth. At a quarterly dividend of $1.69 per share, IBM stock offers a dividend yield of 2.7%.
Following a fireside chat with Ric Lewis, senior vice president of infrastructure at IBM, Bank of America analyst Wamsi Mohan reaffirmed a buy rating on IBM stock and increased his price target to $315 from $300.
The five-star analyst noted that Lewis views IBM Infrastructure as an increasingly less cyclical and more structurally advantaged business, with AI driving additional demand across the entire technology stack rather than only in graphics processing units.
Mohan added that AI tailwinds are most evident in IBM's Z mainframe offering, where program-to-program growth has increased from 110% several generations ago to the range of 120% to 125% in the prior cycle and roughly 135% for Z17. This acceleration is driven by AI workloads moving beyond fraud detection into inferencing areas like insurance, actuarial modeling, and transaction-level intelligence.
The analyst noted that IBM is benefiting from customers upgrading their systems and increased revenue from higher-value workloads from its existing customer base. Mohan also noted other positives like AI-led demand in IBM's storage business and the quantum roadmap.
"Overall, the fireside reinforced that IBM's Infrastructure business is positioned to compound through a combination of accelerating Z demand, AI-driven workload expansion, storage strength, and better monetization across a differentiated full-stack architecture," said Mohan.
Mohan ranks No. 21 among more than 12,300 analysts tracked by TipRanks. His ratings have been successful 65% of the time, delivering an average return of 52.6%. See IBM Insider Trading Activity on TipRanks.
Key Takeaways FMC and Corteva signed a co-exclusive deal to expand rimisoxafen access in the Americas.Corteva will prepay $200 million as FMC retains ownership and supplies the active ingredient.Rimisoxafen-based products are expected to see first commercial sales by decade's end. FMC Corporation (FMC - Free Report) and Corteva, Inc. have announced a co-exclusive strategic supply and license agreement to expand access to FMC’s rimisoxafen herbicide technology across North and South America. The collaboration is expected to help herbicide-resistant weed management solutions for corn and soybean markets while adding to the portfolios of these two leading global agricultural science and innovation companies.
Under the agreement, FMC will retain ownership of rimisoxafen and supply the active ingredient to Corteva. Both companies will independently develop and commercialize exclusive premix formulations for corn and soybean markets throughout the region. Corteva will make an initial prepayment of $200 million for future product supply.
Rimisoxafen has been recognized by the Herbicide Resistance Action Committee as the industry’s first dual mode of action herbicide. Its unique design provides a higher barrier to resistance development compared to traditional single-mode of action products.
The partnership will play a critical role in broadening access to this groundbreaking innovation to control threats to crop yields and farm profitability. Pending regulatory approvals, the first commercial sales of rimisoxafen-based products are anticipated by the end of the decade. The partnership reflects both companies’ commitment to providing sustainable and effective weed management solutions for farmers across the Americas.
FMC shares have plunged 71.3% over the past year against the industry’s 2.9% growth.
Image Source: Zacks Investment Research
FMC’s Zacks Rank & Key PicksFMC currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , Dow Inc. (DOW - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .
While ALB and DOW sport a Zacks Rank #1 (Strong Buy) each at present, ASM carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for ALB’s 2026 earnings is pinned at $12.39 per share, indicating a 1,668.35% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 74.5%. ALB’s shares have jumped 180.4% over the past year.
The Zacks Consensus Estimate for DOW’s 2026 earnings is pegged at $2.61 per share, indicating a rise of 377.66% year over year. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters. DOW’sshares have gained 14.1% over the past year.
The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 39 cents per share, indicating a 34.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 125%.
Key Takeaways MKL acquired The MECO Group to strengthen its marine insurance footprint and global distribution. Acquisitions across insurance and non-insurance businesses help diversify earnings and growth drivers. Management uses underwriting profits and generated capital to fund deals that build long-term value. Markel Group Inc. (MKL - Free Report) uses acquisitions as a key component of its long-term capital allocation strategy. The acquisition strategy is designed to expand specialty insurance capabilities and distribution, enter attractive niche markets with strong underwriting expertise, deploy excess capital into businesses that can compound value over long periods and acquire founder-led businesses that can continue operating independently under a decentralized structure.
Markel Insurance, the company's core specialty insurance business, completed its acquisition of the London-based independent specialist marine managing general agent (MGA), The MECO Group, in June 2025. This strategic integration expands Markel Group's marine insurance footprint, strengthens its presence in the Asia-Pacific and European marine markets, and enhances its distribution relationships and product breadth.
In 2024, Markel Group acquired a majority interest in Valor Environmental and related operating companies, thereby expanding Markel Ventures' industrial and infrastructure operations.
The addition of such companies shows that Markel continues to pursue both insurance and non-insurance acquisitions to strengthen these engines and reduce dependence on any single market cycle.
Markel Group generally funds acquisitions through Insurance underwriting profits, internally generated capital and occasional debt issuance for larger transactions. The company's diversified business model provides multiple sources of cash that can be deployed toward acquisitions.
Acquisitions are a critical pillar of Markel Group's long-term growth strategy. They help the company expand its insurance franchise, diversify earnings, deploy capital efficiently and increase intrinsic value per share.
Markel Group's acquisition strategy differs from many other insurers because it is not focused solely on growing insurance premiums. Management aims to create a diversified collection of high-quality businesses that can compound intrinsic value over decades.
What About Its Peers?Assurant, Inc. (AIZ - Free Report) remains focused on acquisitions to expand its footprint in the connected living, automotive and device repair sectors. Strategic buyouts (such as RL Circular Operations, OptoFidelity, HYLA Mobile and The Warranty Group) fuel its growth by providing proprietary diagnostic technology, scaling circular supply chains and expanding into high-growth international markets. Acquisitions have played a pivotal role in transforming Assurant into a global, technology-driven leader in risk management, beyond its traditional insurance roots.
Arthur J. Gallagher & Co. (AJG - Free Report) is growing through mergers and acquisitions. During 2025, AJG completed 31 new mergers, representing around $3.5 billion of estimated annualized revenues. Looking at the pipeline, AJG has around 40 term sheets signed or being prepared, representing around $350 million of annualized revenues. AJG’s current cash position and strong expected free cash flow position it well for its pipeline of M&A opportunities. Over the next couple of years, AJG expects to have $10 billion to fund M&A, before utilizing any stock.
MKL’s Price PerformanceShares of MKL have lost 5.8% in the past year against the industry’s growth of 1.7%.
Image Source: Zacks Investment Research
MKL’s UndervaluationThe stock is undervalued compared with its industry. Its forward price-to-book value of 1.28X is lower than the industry average of 2.61X. It carries a Value Score of B.
Image Source: Zacks Investment Research
Estimate Movement for MKLThe Zacks Consensus Estimate for MKL’s second-quarter and third-quarter 2026 EPS has both moved down 0.2% and 3.5%, respectively, in the past 60 days. The same for full-year 2026 and 2027 EPS has moved down 3.4% and 3.1%, respectively, in the past 60 days.
The consensus estimate for MKL’s 2026 and 2027 EPS and revenues indicates a year-over-year increase.
Image Source: Zacks Investment Research
MKL stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
In the latest trading session, SM Energy (SM - Free Report) closed at $27.14, marking a -3.38% move from the previous day. The stock's change was less than the S&P 500's daily gain of 1.09%. At the same time, the Dow added 0.14%, and the tech-heavy Nasdaq gained 1.91%.
The independent oil and gas company's stock has dropped by 19.31% in the past month, falling short of the Oils-Energy sector's loss of 7.57% and the S&P 500's gain of 0.29%.
Investors will be eagerly watching for the performance of SM Energy in its upcoming earnings disclosure. The company is forecasted to report an EPS of $1.87, showcasing a 24.67% upward movement from the corresponding quarter of the prior year. In the meantime, our current consensus estimate forecasts the revenue to be $2.05 billion, indicating a 158.24% growth compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $7.3 per share and revenue of $7.56 billion, which would represent changes of +34.69% and +139.56%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for SM Energy. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 5.44% higher. Right now, SM Energy possesses a Zacks Rank of #3 (Hold).
In terms of valuation, SM Energy is currently trading at a Forward P/E ratio of 3.85. Its industry sports an average Forward P/E of 9.26, so one might conclude that SM Energy is trading at a discount comparatively.
The Oil and Gas - Exploration and Production - United States industry is part of the Oils-Energy sector. This group has a Zacks Industry Rank of 108, putting it in the top 45% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Avient (AVNT - Free Report) Avient Corporation is a global specialty-materials company focused on color, additives, inks, engineered polymers, advanced composites, and performance fibers, combining materials science, formulation expertise and manufacturing scale. Formed as PolyOne Corporation on Aug. 31, 2000, the company changed its name to Avient Corporation, effective June 30, 2020.
AVNT is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Additionally, the company could be a top pick for growth investors. AVNT has a Growth Style Score of B, forecasting year-over-year earnings growth of 9.2% for the current fiscal year.
Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.02 to $3.08 per share. AVNT boasts an average earnings surprise of +2.1%.
With a solid Zacks Rank and top-tier Growth and VGM Style Scores, AVNT should be on investors' short list.
Key Takeaways EMCOR is targeting electrical construction deals to expand reach and deepen market density.Electrical Construction's revenues rose 33.1% YoY to a record $1.45B in Q1 2026.AI and cloud demand helped lift Network and Communications revenues nearly 50%. EMCOR Group, Inc. (EME - Free Report) appears to be doubling down on electrical construction acquisitions as it seeks to strengthen its competitive position in some of the fastest-growing end markets, particularly data centers and other mission-critical infrastructure projects.
During the company’s first-quarter 2026 earnings call, management identified electrical construction as EMCOR’s primary M&A focus, targeting low- and medium-voltage contractors to expand its geographic reach and strengthen market density. Rather than paying premium valuations for firms with significant data center exposure, EMCOR aims to acquire well-run electrical businesses and leverage its scale, expertise and customer relationships to enter faster-growing infrastructure markets.
This acquisition strategy is amplifying a segment that is already delivering exceptional organic results. In the first quarter of 2026, EMCOR’s Electrical Construction segment generated a record-breaking $1.45 billion in revenues, representing an extraordinary 33.1% increase year over year. Segment operating income climbed 28.2% to a record $174.5 million. Even with rapid scaling and an incremental month of expenses from its major Miller Electric acquisition, the segment maintained a premier operating margin of 12.1%, underscoring the pricing power and execution discipline of EMCOR's decentralized operating model.
EMCOR’s expanding electrical capabilities are becoming increasingly valuable as demand for AI infrastructure accelerates. Electrical construction’s revenues benefited from nearly 50% growth in network and communications, which includes the company’s data center business, driven by continued investment in AI, cloud computing and digital transformation. The strategy is already translating into stronger visibility, with remaining performance obligations reaching a record $15.62 billion, up 32.9% year over year. Network and Communications was a key contributor, while continued wins across electrical and mechanical scopes reinforce EMCOR’s position in mission-critical infrastructure projects.
With robust demand, a growing acquisition pipeline and a disciplined approach to expanding its electrical platform, EMCOR appears focused on widening its competitive moat. If the company can continue integrating acquisitions and converting them into higher-value opportunities, its edge in mission-critical construction markets may continue to strengthen.
EMCOR’s Competitive Position: Electrical Deals in FocusEMCOR has increasingly focused on expanding its electrical construction capabilities, positioning itself to benefit from growing investments in AI infrastructure, cloud computing, electrification and mission-critical facilities. It competes with established infrastructure players such as Sterling Infrastructure, Inc. (STRL - Free Report) and Quanta Services, Inc. (PWR - Free Report) , which are also benefiting from strong demand tied to data centers, electrification and large-scale infrastructure spending.
The strategy comes as electrical capabilities have become a critical competitive advantage across the industry. Sterling recently highlighted the transformational impact of its acquisition of CEC Facilities Group, an electrical contractor that has enabled the company to offer integrated site development and electrical services on large data center projects. Management noted that cross-selling opportunities are materializing faster than expected and that demand for electricians remains exceptionally strong. Sterling also continues to evaluate acquisitions that can expand its electrical footprint and service offerings.
Quanta, meanwhile, has built one of the industry's largest electrical infrastructure platforms through years of acquisitions and organic investments. The company continues to expand its craft workforce, manufacturing capabilities and supply-chain footprint to support rising power and data center demand. Management emphasized that customers increasingly value execution certainty, labor availability and integrated electrical solutions, helping Quanta secure larger negotiated projects and long-term capital programs.
EME Stock’s Price Performance & Valuation TrendShares of this Connecticut-based infrastructure service provider have gained 36.4% year to date, slightly underperforming the Zacks Building Products - Heavy Construction industry, but outperforming the Construction sector and the S&P 500 Index.
Image Source: Zacks Investment Research
EME stock is currently trading at a premium compared with the industry peers, with a forward 12-month price-to-earnings (P/E) ratio of 27.18, as evidenced by the chart below.
Image Source: Zacks Investment Research
Earnings Estimate Revision of EME StockEME’s earnings estimates for 2026 and 2027 have moved upward in the past 30 days. The estimates for 2026 and 2027 imply year-over-year growth of 13% and 11.2%, respectively.
Image Source: Zacks Investment Research
EMCOR stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?
Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Emcor Group (EME - Free Report) .
Emcor Group currently has an average brokerage recommendation (ABR) of 1.73, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 11 brokerage firms. An ABR of 1.73 approximates between Strong Buy and Buy.
Of the 11 recommendations that derive the current ABR, seven are Strong Buy, representing 63.6% of all recommendations.
Brokerage Recommendation Trends for EME
Check price target & stock forecast for Emcor Group here>>>
While the ABR calls for buying Emcor Group, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.
Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.
In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.
With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.
ABR Should Not Be Confused With Zacks RankIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.
Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.
Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.
In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.
Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.
Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.
Should You Invest in EME?Looking at the earnings estimate revisions for Emcor Group, the Zacks Consensus Estimate for the current year has increased 1.9% over the past month to $29.22.
Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Emcor Group. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Therefore, the Buy-equivalent ABR for Emcor Group may serve as a useful guide for investors.
For those looking to find strong Construction stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Emcor Group (EME - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Construction sector should help us answer this question.
Emcor Group is one of 88 individual stocks in the Construction sector. Collectively, these companies sit at #15 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Emcor Group is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for EME's full-year earnings has moved 3.5% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, EME has gained about 35.3% so far this year. Meanwhile, stocks in the Construction group have gained about 14.8% on average. This means that Emcor Group is performing better than its sector in terms of year-to-date returns.
Knife River (KNF - Free Report) is another Construction stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 18.6%.
In Knife River's case, the consensus EPS estimate for the current year increased 3.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Emcor Group belongs to the Building Products - Heavy Construction industry, a group that includes 8 individual companies and currently sits at #52 in the Zacks Industry Rank. Stocks in this group have gained about 37.4% so far this year, so EME is slightly underperforming its industry this group in terms of year-to-date returns.
In contrast, Knife River falls under the Building Products - Miscellaneous industry. Currently, this industry has 33 stocks and is ranked #191. Since the beginning of the year, the industry has moved +2.8%.
Going forward, investors interested in Construction stocks should continue to pay close attention to Emcor Group and Knife River as they could maintain their solid performance.
Emcor Group (EME - Free Report) ended the recent trading session at $836.59, demonstrating a +1.1% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 1.09%. Elsewhere, the Dow saw an upswing of 0.14%, while the tech-heavy Nasdaq appreciated by 1.91%.
Heading into today, shares of the construction and maintenance company had lost 3.01% over the past month, lagging the Construction sector's gain of 3.92% and the S&P 500's gain of 0.29%.
The investment community will be paying close attention to the earnings performance of Emcor Group in its upcoming release. The company is expected to report EPS of $7.24, up 7.74% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $4.7 billion, indicating a 9.08% increase compared to the same quarter of the previous year.
EME's full-year Zacks Consensus Estimates are calling for earnings of $29.22 per share and revenue of $18.83 billion. These results would represent year-over-year changes of +12.95% and +10.86%, respectively.
It's also important for investors to be aware of any recent modifications to analyst estimates for Emcor Group. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 1.9% higher. As of now, Emcor Group holds a Zacks Rank of #2 (Buy).
Valuation is also important, so investors should note that Emcor Group has a Forward P/E ratio of 28.32 right now. This expresses a premium compared to the average Forward P/E of 20.71 of its industry.
The Building Products - Heavy Construction industry is part of the Construction sector. This industry, currently bearing a Zacks Industry Rank of 52, finds itself in the top 22% echelons of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.73 per common share. This dividend will be paid July 24, 2026 to shareholders of record as of July 6, 2026. This dividend represents the company’s 127th consecutive regular quarterly cash dividend payment.
IDEX Corp. (NYSE:IEX) announces a regular quarterly cash dividend of $0.73 per common share, its 127th consecutive such payment.
Share About IDEX
IDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments – Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products. Thousands of IDEX employees around the world design and manufacture highly engineered components and applied solutions that are vital to the advances of modern life and help IDEX live its purpose – Trusted Solutions, Improving Lives™. From satellite communications to water systems, from medical diagnostic components to emergency rescue tools and more, we collaborate with customers in the most critical industries to develop solutions that make the world better today and into the future. Founded in 1988, IDEX now includes more than 50 dynamic businesses around the world and manufacturing operations in more than 20 countries. Learn more about the impactful work we do at www.idexcorp.com.
Key Takeaways DLTR trades below key retail benchmarks, though its price target implies only measured upside.DLTR raised its earnings outlook as multi-price, freight and shrink gains support profit momentum.DLTR faces pressure from softer traffic, higher SG&A costs, tariffs and transportation expenses. Dollar Tree, Inc. (DLTR - Free Report) offers a more interesting setup after stronger earnings, higher guidance and improving execution. The stock also trades at a valuation that looks less demanding than many retail benchmarks.
That does not make the buy case automatic. Traffic is still soft, cost pressure remains visible and the stock’s broader profile points to progress with limits.
DLTR Valuation Looks Less DemandingDollar Tree trades at 15.39 times forward 12-month earnings. That is below the Zacks sub-industry at 31.39 times, the broader Zacks sector at 22.78 times and the S&P 500 at 21.34 times.
Image Source: Zacks Investment Research
This discount can appeal to investors looking for a cheaper retail multiple tied to a company with improving earnings. Still, the $118 price target implies only measured upside from the cited share price of $111.65, which keeps valuation from looking like a clear bargain.
Dollar Tree Gets an Earnings ResetDollar Tree’s first-quarter fiscal 2026 results changed the earnings discussion. Adjusted earnings per share rose 38% year over year to $1.74, topping expectations and showing that better execution is reaching the bottom line.
The company also raised its full-year adjusted earnings per share outlook to $6.70-$7.10 from the prior range of $6.50-$6.90. That creates a stronger profit setup, especially as multi-price penetration, lower freight costs and better shrink performance support earnings momentum.
DLTR Has Cash Flow to Back the StoryDollar Tree’s financial position adds support to the investment case. The company ended the first quarter with $1 billion in cash, no borrowings under its credit facilities and no commercial paper outstanding.
Free cash flow reached $392 million in the quarter. Dollar Tree also repurchased about $595 million of shares and plans $1.1 billion to $1.2 billion in capital expenditures for fiscal 2026, showing room to invest in stores, distribution and assortment while returning capital.
Dollar Tree Still Faces Real FrictionThe caution case remains meaningful. Selling, general and administrative expenses increased 50 basis points to 27.8% of total revenue in the first quarter, reflecting higher marketing costs, general liability costs and depreciation tied to store investments.
Traffic is another pressure point. Comparable sales rose 3.5%, but the gain came from a 4.5% increase in average ticket while traffic declined 1%. Tariff uncertainty, higher fuel costs and transportation expenses add further risk to margin consistency.
Dollar General Corporation (DG - Free Report) is a relevant peer because both companies serve value-focused shoppers navigating pressure on household budgets. Five Below Inc. (FIVE - Free Report) also provides useful context, as discretionary value retail depends heavily on traffic, affordability and assortment appeal.
DLTR Offers a Mixed Risk-RewardDollar Tree’s investment case is better than it was when earnings visibility looked weaker. The stock has a lower multiple than key benchmarks, higher earnings guidance and enough cash flow to fund growth initiatives.
The issue is the limited room for error. Margin resilience and comparable-store sales growth must continue long enough to support further estimate gains. If macro pressure keeps traffic subdued or costs rise faster than planned, the shares could stay range-bound.
What DLTR’s Zacks Rank Signals NowThe bottom line is that DLTR has improving fundamentals, but not a clean all-clear. The stock currently carries a Zacks Rank #3 (Hold), which fits a profile where investors can recognize progress while waiting for stronger confirmation.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Style Scores add a more favorable layer. DLTR has a VGM Score of A, Growth Score of A, Momentum Score of A and Value Score of B. The combination supports a cautious-but-interesting investment profile, with the valuation discount and earnings momentum offset by traffic, tariff and expense risks.
Key Takeaways DLTR is shifting beyond one-price retail with broader assortments, larger pack sizes and more choice.DLTR's comparable sales rose as higher ticket offset softer traffic from more selective shoppers.DLTR is using delivery, new stores and margin execution to support a modern value-retail model. Dollar Tree, Inc. (DLTR - Free Report) is showing how value retail is changing. The model is no longer defined only by the lowest opening price.
The newer playbook depends on broader assortment, higher basket size, sharper execution and stronger convenience. Dollar Tree’s latest results make that shift clear, even as pressure on consumers keeps the story balanced.
Dollar Tree Expands Beyond One PriceDollar Tree’s move into a broader multi-price format marks a major structural change for the chain. The company is using the format to offer higher-quality items, larger pack sizes and more choice across categories.
That does not mean the value message is being abandoned. Management has emphasized that the opening price point remains central to the brand, while the expanded price architecture gives the company more room to improve assortment relevance and product quality.
DLTR Leans on Ticket Over TrafficFirst-quarter fiscal 2026 comparable-store sales rose 3.5%, but the composition matters. Average ticket increased 4.5%, while traffic declined 1%.
That mix points to a more selective shopper. Customers are still spending, but they are doing so with greater focus on value, convenience and need-based trips. For Dollar Tree, that raises the importance of assortment, price communication and consistent store execution.
Dollar Tree Turns Execution Into Margin SupportMargin improvement is another sign of how discount retail is evolving. Dollar Tree’s gross margin expanded 120 basis points in the first quarter, helped by higher mark-on, lower freight costs and lower shrink.
Adjusted operating margin rose 110 basis points to 9.5%. The drivers show that value retailers cannot rely on price alone. Product protection, shrink control, field discipline and freight efficiency are becoming key parts of the earnings formula.
Image Source: Zacks Investment Research
DLTR Builds Reach Through Stores and DeliveryDollar Tree is also expanding the ways it reaches customers. The company opened 113 new stores in the first quarter and ended the period with 9,382 stores.
Delivery access is becoming part of the model as well. As of Jan. 31, 2026, more than 8,800 Dollar Tree stores were serviceable through Uber Eats, giving the banner another way to reach younger and time-constrained shoppers. Distribution center investments are also aimed at supporting larger assortments, better in-stock levels and more reliable execution.
Dollar Tree Faces the Limits of the TrendThe shift toward broader value retail still faces real limits. Tariffs and markdowns partially offset first-quarter gross margin gains, while higher fuel costs and transportation uncertainty remain risks for the rest of fiscal 2026.
Consumer pressure is another constraint. Lower-income households remain cautious, and shopping behavior is still closer to need. That makes traffic recovery a key test for Dollar Tree and other value retailers.
Dollar General Corporation (DG - Free Report) offers a useful peer comparison because it also serves shoppers focused on affordability and everyday essentials. Five Below Inc. (FIVE - Free Report) adds another lens, as its extreme-value model depends on discretionary appeal, trend-right merchandise and frequent customer visits.
How DLTR’s Zacks Rank Frames the TrendThe bottom line is that Dollar Tree is participating in attractive retail shifts, but the stock is not yet a clean high-conviction call. Multi-price expansion, delivery access and margin execution all point to a more modern value-retail model.
DLTR currently carries a Zacks Rank #3 (Hold). That rank fits a company making operational progress while still navigating traffic pressure, tariff uncertainty and cost headwinds.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Style Scores are more encouraging. DLTR has a VGM Score of A, Growth Score of A, Momentum Score of A and Value Score of B. Those marks suggest favorable underlying traits for investors tracking trend-backed retailers, while the Zacks Rank keeps the broader stance measured.
Key Takeaways Dollar Tree is now centered on the Dollar Tree banner after completing the Family Dollar sale.Dollar Tree's multi-price rollout is supporting broader assortments and stronger ticket growth.Dollar Tree's margin gains reflect higher mark-on, lower freight costs and improved shrink control. Dollar Tree, Inc. (DLTR - Free Report) has become a more focused investment story, with the Dollar Tree banner now carrying the operating narrative after the Family Dollar sale. The stock’s outlook depends on whether stronger execution, multi-price expansion and margin progress can offset weaker traffic and a cautious consumer backdrop.
The latest setup is constructive, but not one-sided. Sales are growing, guidance has moved higher and margins are improving, yet investors still need evidence that traffic can recover.
Dollar Tree After the Family Dollar ExitDollar Tree completed the sale of Family Dollar on Jul. 5, 2025, making the Dollar Tree banner the company’s core operating brand. That shift gives investors a cleaner business to evaluate, centered on discount variety stores in the United States and Canada.
The transition is still not fully complete. Dollar Tree is providing a breakup of corporate selling, general and administrative expenses through fiscal 2026 to aid comparability after the divestiture. It also continues to provide certain transition services to the buyer of Family Dollar, which makes the operating story cleaner but still evolving.
DLTR Finds Growth in Multi-PriceMulti-price remains one of Dollar Tree’s most important growth levers. The format allows the company to offer higher-quality items, larger pack sizes and broader category choices while preserving its value positioning.
By the end of the first quarter of fiscal 2026, Dollar Tree had about 5,900 multi-price stores, after converting or adding roughly 630 stores in the quarter. The broader assortment is helping basket composition across consumables and discretionary categories, with ticket growth reflecting stronger multi-price penetration and more relevant products.
Dollar Tree Margins Improve on Better ExecutionThe margin story matters as much as sales growth in the current setup. In the first quarter of fiscal 2026, gross margin expanded 120 basis points (bps), driven mainly by higher mark-on, lower freight costs and lower shrink.
Adjusted operating income rose 22% year over year to $473.3 million, while adjusted operating margin expanded 110 bps to 9.5%. These gains show that internal execution, including better shrink control and freight benefits, is playing a bigger role in the earnings recovery than simple top-line growth.
Image Source: Zacks Investment Research
DLTR Still Needs Traffic to ReboundThe mixed part of the story is traffic. First-quarter comparable sales increased 3.5%, but that gain was driven by a 4.5% increase in average ticket, partly offset by a 1% decline in traffic.
That puts trip frequency near the center of the investment debate. Lower-income shoppers remain under pressure from higher fuel costs, inflation in essentials and broader macro uncertainty. Dollar General Corporation (DG - Free Report) is a relevant comparison because it also competes for value-driven essentials trips. Five Below Inc. (FIVE - Free Report) offers another point of comparison in discretionary value retail, where assortment freshness and price perception influence customer visits.
Dollar Tree Outlook Rises, but Risks RemainDollar Tree raised its fiscal 2026 adjusted earnings outlook after the stronger first quarter. The company now expects net sales from continuing operations of $20.5 billion to $20.7 billion, comparable-store sales growth of 3% to 4% and adjusted earnings per share of $6.70 to $7.10.
The outlook is not risk-free. Tariffs, markdowns, higher fuel costs, selling, general and administrative expense pressure and consumer softness remain key constraints. Management expects gross margin to be roughly flat for fiscal 2026, as merchandise margin and freight benefits are offset by tariffs and markdown pressure.
How DLTR’s Zacks Rank Fits the SetupThe bottom line is that Dollar Tree’s execution has improved, but the stock still carries a balanced risk-reward profile. Multi-price growth and margin recovery support the bull case, while traffic softness and cost uncertainty keep near-term visibility limited.
The stock currently carries a Zacks Rank #3 (Hold), which is consistent with a business showing progress but not enough clarity to support a more aggressive stance. Its Style Scores are stronger, with a Growth Score of A, Momentum Score of A, Value Score of B and VGM Score of A.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Those scores point to attractive growth, momentum and combined style characteristics. For investors, the combination suggests DLTR has favorable underlying traits, but the Zacks Rank keeps the broader view measured until traffic and cost pressures show steadier improvement.
Making its debut on 11/15/2007, smart beta exchange traded fund Invesco Bloomberg Enhanced Fallen Angels ETF (IFLN - Free Report) provides investors broad exposure to the High-Yield/Junk Bond ETFs category of the market.
What Are Smart Beta ETFs?The ETF industry has long been dominated by products based on market cap weighted indexes, a strategy created to reflect the market or a particular market segment.
Because market cap weighted indexes provide a low-cost, convenient, and transparent way of replicating market returns, they work well for investors who believe in market efficiency.
On the other hand, some investors who believe that it is possible to beat the market by superior stock selection opt to invest in another class of funds that track non-cap weighted strategies--popularly known as smart beta.
This kind of index follows this same mindset, as it attempts to pick stocks that have better chances of risk-return performance; non-cap weighted strategies base selection on certain fundamental characteristics, or a mix of such characteristics.
This area offers many different investment choices, such as simplest equal-weighting, fundamental weighting and volatility/momentum based weighting methodologies; however, not all of these strategies can deliver superior results.
Fund Sponsor & IndexThe fund is managed by Invesco. IFLN has been able to amass assets over $320.07 million, making it one of the average sized ETFs in the High-Yield/Junk Bond ETFs. IFLN, before fees and expenses, seeks to match the performance of the BLOOMBERG US HGH YLD ENHCD FLN ANGL ID .
The Bloomberg US High Yield Enhanced Fallen Angels Index comprises of U.S. dollar-denominated high yield corporate bonds.
Cost & Other ExpensesExpense ratios are an important factor in the return of an ETF and in the long-term, cheaper funds can significantly outperform their more expensive cousins, other things remaining the same.
Operating expenses on an annual basis are 0.23% for IFLN, making it one of the least expensive products in the space.
It has a 12-month trailing dividend yield of 5.80%.
Sector Exposure and Top HoldingsMost ETFs are very transparent products, and disclose their holdings on a daily basis. ETFs also offer diversified exposure, which minimizes single stock risk, though it's still important for investors to research a fund's holdings.
Looking at individual holdings, Gfl Environmental Inc-6.75%-01-15-2031 (GFLCN) accounts for about 4.72% of total assets, followed by Pacificorp-7.38%-09-15-2055 (BRKHEC) and Vodafone Group Plc-7.00%-04-04-2079 (VOD).
Its top 10 holdings account for approximately 28.2% of IFLN's total assets under management.
Performance and RiskSo far this year, IFLN has gained about 0.1%, and it's up approximately 0% in the last one year (as of 06/18/2026). During this past 52-week period, the fund has traded between $17.78 and $18.58.
IFLN has a beta of 0.38 and standard deviation of 0.00% for the trailing three-year period. With about 114 holdings, it effectively diversifies company-specific risk .
AlternativesInvesco Bloomberg Enhanced Fallen Angels ETF is a reasonable option for investors seeking to outperform the High-Yield/Junk Bond ETFs segment of the market. However, there are other ETFs in the space which investors could consider.
iShares iBoxx $ High Yield Corporate Bond ETF (HYG) tracks Markit iBoxx USD Liquid High Yield Index and the iShares Broad USD High Yield Corporate Bond ETF (USHY) tracks BofA Merrill Lynch U.S. High Yield Constrained Index. iShares iBoxx $ High Yield Corporate Bond ETF has $16.21 billion in assets, iShares Broad USD High Yield Corporate Bond ETF has $27.79 billion. HYG has an expense ratio of 0.49% and USHY changes 0.08%.
Investors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the High-Yield/Junk Bond ETFs
Bottom LineTo learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.
Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS 0.28%) provides diversified exposure to defensive stocks, while iShares U.S. Consumer Staples ETF (IYK +0.29%) offers a more concentrated, market-cap-weighted portfolio with historically stronger total returns.
Both funds focus on the consumer staples sector, which investors often seek out as a defensive harbor during market volatility. While RSPS treats every constituent equally to avoid overexposure to giant companies, IYK follows a traditional market-cap approach that leans heavily on industry leaders.
Snapshot (cost & size)MetricRSPSIYKIssuerInvescoiSharesExpense ratio0.40%0.38%1-yr return (as of June 18, 2026)0.1%2.9%Dividend yield2.8%2.7%Beta0.590.50AUM$225.5 million$1.3 billionBeta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Both funds are cost-efficient, though the iShares fund is slightly more affordable. While RSPS offers a slightly higher dividend yield of 2.8%, IYK provides a similar payout at 2.7%.
Performance & risk comparisonMetricRSPSIYKMax drawdown (5 yr)(18.60%)(15.00%)Growth of $1,000 over 5 years (total return)$1,071$1,381What's insideThe iShares ETF targets U.S. companies in the consumer defensive sector using a market-capitalization-weighting strategy. With 54 holdings, its largest positions include Procter & Gamble (PG 0.40%) at 13.45%, Coca-Cola(KO +0.08%) at 12.38%, and Philip Morris International (PM +0.07%) at 11.14%. The portfolio is primarily composed of consumer defensive stocks at 85%, with additional exposure to healthcare at 11% and basic materials at 3%. Launched in 2000, it has a trailing-12-month dividend payout of $1.89 per share.
In contrast, the Invesco ETF tracks the S&P 500 Equal Weight Consumer Staples Index, which assigns an equal weight to every staples company in the S&P 500. This 37-holding portfolio includes Monster Beverage (MNST +0.68%) at 3.32%, Casey's General Stores (CASY 0.58%) at 3.30%, and Keurig Dr Pepper (KDP 0.05%) at 3.18%. It is heavily concentrated in consumer defensive stocks. Launched in 2006, it has a trailing-12-month dividend payout of $0.84 per share.
For more guidance on ETF investing, check out the full guide at this link.
What this means for investorsWhile I think both of these ETFs would likely appeal to defensive investors, the fundamental difference in their approach to position sizing is probably the deciding factor in choosing one over the other.
RSPS may be more attractive to conservative investors given its equal-weight strategy; the smaller position sizing reduces concentration risk. Due to IYK's market-cap-weighting approach, the ETF is inherently far more reliant on just a few stocks to fuel its performance. The fund's top three holdings -- P&G, Coca-Cola, and Philip Morris -- account for roughly 37% of the portfolio. And while these are generally stalwart stocks, investors might want to note that P&G has underperformed the market by a wide margin over the past five years, up only 14% versus the S&P 500's 80% gain. Despite that, the iShares ETF has delivered better returns recently.
One final thing to consider is their relative size. RSPS has significantly fewer assets under management, as well as much lower average trading volume. If liquidity is an important consideration, IYK may be the better option for your portfolio.
Erin Kennedy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Monster Beverage. The Motley Fool recommends Casey's General Stores and Philip Morris International. The Motley Fool has a disclosure policy.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Invesco (IVZ - Free Report) Headquartered in Atlanta, GA, Invesco Ltd. operates as an independent investment manager and offers a wide range of investment products and services. The company was incorporated in 1935. As of March 31, 2026, Invesco served clients in more than 120 countries and had AUM worth $2.16 trillion.
IVZ is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 10.92; value investors should take notice.
Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.06 to $2.58 per share. IVZ boasts an average earnings surprise of +7.9%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, IVZ should be on investors' short list.
Invesco KBW Bank ETF (KBWB +1.11%) offers broader exposure to major U.S. money center banks and national institutions, while iShares U.S. Regional Banks ETF (IAT +0.57%) provides a more concentrated bet on the domestic regional banking sector.
These ETFs allow investors to target the financial sector with differing levels of specificity. While both concentrate on bank equities, their underlying indexes select and weigh holdings differently, leading to variations in liquidity, price volatility, and total returns. With assets under management (AUM) exceeding $6 billion, KBWB offers deeper liquidity than the smaller IAT.
Snapshot (cost & size)MetricIATKBWBIssueriSharesInvescoExpense ratio0.38%0.35%1-yr return (as of June 19, 2026)27.8%37.8%Dividend yield2.8%2.1%Beta1.281.26AUM$624.3 million$6.3 billionBeta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
The Invesco fund is marginally more affordable than the iShares ETF, but that 3-basis-point difference is unlikely to sway an investor one way or another. However, IAT may appeal to income-oriented investors due to its higher trailing-12-month dividend yield of 2.8%.
Performance & risk comparisonMetricIATKBWBMax drawdown (5 yr)(55.5%)(49.3%)Growth of $1,000 over 5 years (total return)$1,264$1,744What's insideThe Invesco ETF tracks the KBW Nasdaq Bank Index, which focuses on national money centers and regional establishments. Its portfolio of 26 holdings leans into diversified financial giants. Its largest positions include Morgan Stanley (MS +1.55%) at 9.49%, Goldman Sachs (GS +0.52%) at 8.99%, and Bank of America (BAC +2.10%) at 7.97%. Launched in 2011, it has a trailing-12-month dividend payout of $1.80 per share.
Conversely, the iShares fund offers more targeted exposure, strictly following U.S.-based stocks within the regional banking industry. It holds 31 companies, all within the financial services sector. Its largest positions include PNC Financial (PNC +0.84%) at 14.67%, U.S. Bancorp (USB +0.86%) at 14.17%, and Truist Financial (TFC +1.30%) at 9.6%. Launched in 2006, IAT has a trailing-12-month dividend payout of $1.62 per share.
For more guidance on ETF investing, check out the full guide at this link.
What this means for investorsAt a glance, Invesco's ETF may be more appealing to most investors. KBWB has posted higher returns recently and a lower five-year max drawdown. It pays a smaller dividend, but investors know a dividend yield moves inversely to a stock's price; when a stock goes up, the dividend will fall, all else equal. The Invesco ETF's one- and five-year returns could more than account for its slightly lower dividend yield. Finally, the fund is roughly 10 times the size of IAT, with much higher average trading volume and accordingly increased liquidity.
One final consideration is concentration risk. KBWB's top three holdings make up about 26% of the fund. Meanwhile, IAT's three largest positions account for about 38% of the portfolio. Some investors may not feel comfortable with that level of concentration in the iShares ETF, myself among them.
Bank of America is an advertising partner of Motley Fool Money. Erin Kennedy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Goldman Sachs Group, Truist Financial, and U.S. Bancorp. The Motley Fool has a disclosure policy.
Pre-Market Stock Futures: Futures are trading mixed as we prepare to finish the last full week of the second quarter. We finished a wild holiday-shortened trading week last Thursday, as Friday was the federal Juneteenth holiday, and all major indices rebounded smartly from the Federal Reserve-induced sell-off on Wednesday. Details of the signed memorandum of understanding between the United States and Iran helped push oil prices back to the lowest level since March, and provided a strong tailwind for stocks. When the final bell rang last Thursday, the small-cap Russell 2000 led the way once again. closing up 2.12% at 2,979, while the Nasdaq also posted a strong day, finishing the session at 26,517, up 1.91%. The S&P 500 finished up 1.08% at 7,500, while the Dow Jones Industrials closed out the day at 51,564, up 0.14%.
Treasury Bonds: Yields were mixed across the curve on Thursday as buyers came in on the long end, while sellers were concentrated on the belly and short end maturities of the curve. By the close, the 30-year-long bond was spotted at 4.90%, and the 10-year benchmark note was last seen at 4.46%. Following the hawkish tone at the Federal Reserve meeting last week, bond traders will be keeping a close eye on incoming economic data. They will closely monitor the 2-year note, which is the most policy-sensitive maturity.
Oil and Gas: The energy complex, which rallied big last week on the potential for an end to the war with Iran, closed modestly higher to finish off the short trading week. The positive attitude, while encouraging for traders and consumers, is being challenged by some on Wall Street, who have issued warnings this week stating that reopening the Strait of Hormuz is not the same as restoring normal oil flows. That could take some time, so spot oil prices could stay higher than many expect, and may have fallen too fast. Brent Crude closed Thursday at $79.53, down just 0.03%, while West Texas Intermediate was last seen at $75.61, down 0.53%. Natural gas, which had a strong week, closed Thursday at $3.22, up 2.45%.
Gold: Gold wrapped up the shortened week modestly lower as a strong dollar weighed on the precious metal, despite continued gigantic gold purchases by China. When the smoke cleared on Thursday, Gold was last seen at $4,215, down 0.97%, while Silver closed at $65.93, down 3.12%.
Crypto: Cryptocurrencies fell sharply on Thursday, weighed down by a broad sell-off across the cryptocurrency market. Bitcoin plunged around 5% to approximately $62,500, while Ethereum and XRP slid 5–6% during the day. The rapid decline triggered liquidations of over $200 million across crypto positions in just a few hours, pushing the total cryptocurrency market capitalization down to roughly $2.15 trillion. At 8 AM EDT, Bitcoin was quoted at $64,038, while Ethereum was trading at $1,766.
24/7 Wall St. reviews dozens of analyst research reports every day to identify fresh investment ideas for investors and traders alike. These daily analyst notes include recommendations on stocks to buy, sell, or avoid, as well as new coverage initiations. Important reminder: No single analyst report should ever be the sole basis for buying or selling a stock.
Here are some of the best Wall Street analyst upgrades, downgrades, and initiations seen on Monday, June 22, 2026.
Upgrades: APA Corporation (NYSE: APA | APA Price Prediction) was upgraded to Buy from Neutral at Roth Capital, which bumped the target price for the energy giant to $38 from $37. BWX Technologies (NYSE: BWXT) was upgraded to Buy from Neutral at Seaport Research, with a $245 target price objective. ConocoPhillips (NYSE: COP) was upgraded to Buy from Neutral at Roth Capital, which moved the target price for the integrated energy leader to $130 from $124. Incyte (NASDAQ: INCY) was raised to Market Perform from Underperform by BMO Capital, which lifted the target price for the stock to $94 from $75. Kimco Realty (NYSE: KIM) was upgraded to Outperform from Peer Perform at Wolfe Research, with a $28 target price. rating Downgrades: Accenture (NYSE: ACN) was downgraded to Hold from Buy at TD Cowen, which slashed the price target for the shares to $150 from $258. Apple (NASDAQ: AAPL) was downgraded to Hold from Outperform at KGI Securities, which has a $315 target price for the tech giant. Cleveland-Cliffs (NYSE: CLF) was downgraded to Equal Weight from Overweight at Morgan Stanley, which nudged the target price to $12.50 from $12. Melco Resorts & Entertainment (NASDAQ: MLCO) was cut to Equal Weight from Overweight at Morgan Stanley, which trimmed the target price for the stock to $6 from $6.30. TE Connectivity (NYSE: TEL) was cut to In Line from Outperform at Evercore ISI, which cut the target price for the shares to $230 from $260. Initiations: Boyd Gaming (NYSE: BYD) was initiated with a Buy rating at Benchmark, which has a $100 target price for the stock. Credo Technology Group Holding (NASDAQ: CRDO) was started with an Outperform rationg at Evercore ISI, with a $325 target price. Estee Lauder Companies (NYSE: EL) was reinstated with a Buy rating at Goldman Sachs, with a $100 target price.
Hut 8 (NASDAQ: HUT) was initiated with a Buy rating at Lucid Capital, with a $226 target price. Space Exploration Technologies (NASDAQ: SPCX) was started with a Sector Weight rating at KeyBanc without a price target.
On June 17, 2026, Match Group Inc MTCH shares fell 3.4% to $35.30, continuing a mixed performance over the past month. The stock has traded in a 52-week range between $28.81 and $39.20.
GF Value™ verdict: shares are currently priced at $35.30, which is 6.9% below the GF Value™ estimate of $37.90.GF Score™ of 82/100 indicates a strong overall performance across key financial metrics.Notable signal: insider activity shows that insiders sold $0.2M in the last 3 months, with no buying reported. Is MTCH Overvalued or Undervalued? Match Group Inc is currently trading at $35.30, which is below the GF Value™ estimate of $37.90, suggesting that the stock is undervalued by approximately 6.9%. This margin of safety may present a buying opportunity for investors looking for stocks with solid fundamentals but trading below intrinsic value. The GF Valuation label indicates that the stock is fairly valued, which aligns with the current market environment but also highlights potential growth opportunities given the undervaluation relative to its estimated intrinsic value.
GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates. However, it is important to consider the risks associated with investing in a company with a Financial Strength rating of 4/10, indicating potential weaknesses in its balance sheet and overall financial health.
How Does MTCH's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 13.5x 18.6x Forward P/E 13.3x N/A The current P/E (TTM) of 13.5x is significantly below its 5-year median P/E of 18.6x, indicating that the stock is trading at a lower valuation compared to its historical average. This P/E analysis aligns with the GF Value™ verdict, reinforcing the view that MTCH is undervalued in relation to its historical performance.
What Does MTCH's GF Score™ Tell Us? Metric Rating GF Score™ 82/100 Financial Strength 4/10 Profitability 8/10 Growth 6/10 Valuation 9/10 Momentum 8/10 The GF Score™ of 82/100 suggests that Match Group Inc has strong fundamentals, particularly in the areas of profitability and valuation, where it scored 8/10 and 9/10, respectively. However, the Financial Strength score of 4/10 indicates that the company may face challenges in maintaining a robust financial position, which could be a concern for long-term investors.
What Are Insiders Doing with MTCH Stock? Recent insider activity shows that insiders sold $0.2M worth of shares in the last three months, with no buying activity reported. This pattern may suggest a lack of confidence from insiders in the short-term outlook of the company, which could be a red flag for potential investors. However, it is also important to note that insider selling does not always indicate negative sentiment, as it may be part of personal financial planning or diversification strategies.
What This Means for Investors Based on the GF Value™ assessment, Match Group Inc MTCH appears to be undervalued at the current price of $35.30, which is 6.9% lower than the GF Value™ estimate of $37.90. However, potential investors should consider the company's financial strength indicators and recent insider selling when evaluating their investment decisions.
For the complete analysis, visit the Match Group Inc MTCH stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is MTCH's GF Score™?
MTCH has a GF Score™ of 82/100, indicating strong overall performance across key financial metrics, which suggests a favorable long-term outlook.
Is MTCH overvalued or undervalued?
MTCH is currently undervalued, with a GF Value™ estimate of $37.90 compared to its current price of $35.30, representing a 6.9% upside potential.
What is MTCH's P/E ratio?
MTCH's P/E ratio is 13.5x, which is significantly below its 5-year median P/E of 18.6x, suggesting the stock is trading at a lower valuation compared to its historical average.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Kevin Warsh just had his first meeting as the new Federal Reserve chairman. In what was a highly anticipated decision, the world's most powerful central bank chose unanimously to keep the benchmark federal funds rate unchanged within a range of 3.5% to 3.75%.
Half of the meeting's participants also expect at least one rate hike in 2026. This is unwelcome news for investors who were hoping for a more accommodative interest rate policy. Blame it on elevated inflation levels.
But Costco Wholesale (COST 1.29%) shareholders aren't worried. Here is one clear reason why the Fed's moves are no match for this top retail stock.
Image source: The Motley Fool.
Consumers always want low prices Costco is such an unbelievably resilient business that it really doesn't matter what stance central bankers are taking. Whether rates are rising or falling, the consumers who shop at the company's warehouses want low prices on high-quality goods. This will always be the case.
Just this decade, there have been multiple examples of this company continuing to perform at a high level regardless of the macro situation.
When the COVID-19 pandemic ravaged the global economy in 2020, most retailers were devastated. Costco, on the other hand, shone. In fiscal 2020 (ended Aug. 30, 2020), it reported same-store sales (SSS) growth of 7.7%. Households were able to rely on Costco's warehouses as one-stop shops to get all of their essentials.
In 2022 and 2023, the Federal Reserve embarked on an aggressive pace of raising interest rates to combat surging inflation. Costco was unfazed. SSS grew 14.4% and 3% in fiscal 2022 and fiscal 2023, respectively.
Even in today's climate, as May's Consumer Price Index reached a level not seen in three years due to the Middle East conflict, Costco keeps humming along. During the four-week period that ended May 31, the business posted an SSS gain of 12.5%. Even excluding changes in gas prices and foreign exchange, this key metric rose 8%.
Today's Change
(
-1.29
%) $
-12.44
Current Price
$
953.15
Stability might be why shares are always expensive If you're an investor who's concerned about the highly uncertain economic environment, then it's natural to wonder if you should buy Costco shares right now. Owning the stock can add some peace of mind. Even with shares trading 13% off their peak, though, I'm not sure adding the business to your portfolio is a smart move.
Costco's stable financial performance might be the main reason the stock is always expensive. The market is asking investors to pay a price-to-earnings ratio of 47.9. Despite the company's consistent SSS growth, that's a steep valuation that offers no margin of safety.
Recognition highlights Five9’s commitment to creating an environment where employees can innovate, grow, and help shape the future of customer experience
SAN RAMON, Calif.--(BUSINESS WIRE)--Five9, Inc. (NASDAQ: FIVN), provider of the Intelligent CX Platform, today announced it has been recognized by Newsweek as one of America’s Greatest Workplaces in Tech 2026 and named to America’s Greatest Workplaces for Perks & Benefits 2026. Five9 received a 4 out of 5-star rating on Newsweek’s list of America’s Greatest Workplaces in Tech 2026 and received a 4 out of 5-star rating on Newsweek’s list of top workplaces for perks and benefits among organizations with 1,000 to 2,500 employees.
These recognitions reflect Five9’s continued investment in fostering a workplace where employees are empowered to innovate, collaborate, and advance the company’s leadership in AI-powered customer experience, helping organizations embrace emerging technologies and navigate one of the most significant transformations reshaping the industry today.
“As AI continues to reshape how businesses engage with customers, the talent, creativity, and dedication of our employees continue to drive meaningful impact for organizations around the world,” said Tiffany Meriweather, Chief Administrative Officer and Chief Legal Officer, Five9. “Our teams are helping customers embrace new technologies responsibly, improve outcomes, and deliver more seamless experiences. These recognitions are a testament to the innovation, collaboration, and commitment our employees bring every day to our customers, partners, and one another.”
Five9 supports more than 3,000 customers worldwide through its Intelligent CX Platform, helping organizations modernize customer engagement with AI, automation, and human expertise. The company continues to invest in programs, benefits, and professional development opportunities designed to support employee well-being, career growth, and long-term success.
The Newsweek rankings are based on independent research and employee feedback evaluating workplace culture, employee satisfaction, compensation and benefits, work-life balance, career development opportunities, and other factors that contribute to a positive employee experience.
In addition to being named by Newsweek to both America’s Greatest Workplaces in Tech 2026 list and Top Workplaces for Perks & Benefits list, Five9 has recently been recognized on the 2026 Fortune Best Workplaces in the Bay Area list, by Computerworld as one of the Best Places to Work in IT for the third consecutive year and by Newsweek as one of America’s Greatest Workplaces for Culture, Belonging, and Community. These recognitions reflect Five9’s ongoing commitment to fostering a workplace where employees can thrive, grow their careers, and help shape the future of customer experience through innovation and collaboration.
For more information about careers at Five9, visit the careers page.
About Five9
Five9 empowers organizations to create hyper-personalized and effortless AI-driven customer experiences that deliver better business outcomes. Powered by Five9 Genius AI, the Five9 Intelligent CX Platform is trusted by 3,000+ customers and 1,400+ partners globally. The New CX starts here, and it's at the heart of every winning experience. For more information, visit www.five9.com.
Tiffany N. Meriweather, Chief Administrative and Legal Officer at Five9 (FIVN +0.18%), reported the direct sale of 29,817 shares in open-market transactions on May 13 and May 14, 2026, according to the SEC Form 4 filing.
Transaction summaryMetricValueShares sold (direct)29,817Transaction value$627,600Post-transaction shares (direct)281,298Post-transaction value (direct ownership)~$5.92 millionTransaction and post-transaction values based on SEC Form 4 weighted average reported price ($21.05).
Key questionsHow does this transaction compare to Meriweather's historical selling activity?
This was Meriweather's largest single direct sale to date, surpassing the previous high of 7,861 shares sold in September 2025 and exceeding the average of 12,618 shares per sale across four historical sell events.What proportion of Meriweather's Five9 holdings did this sale represent?
The transaction accounted for 9.6% of direct holdings at the time, reducing direct ownership from 311,115 to 281,298 shares, with no indirect or derivative holdings reported post-sale.Was the transaction timed at a premium or discount to recent trading?
Shares were sold at a weighted average price of around $21.05 per share, roughly in line with the May 14, 2026 market close, and reflecting a period when Five9 shares had declined 22.40% over the previous year.What does the transaction indicate about selling cadence and capacity?
The elevated size of this transaction follows a period of incremental sales and reflects both the shrinking available share base and a shift to larger, less frequent trades as direct holdings decrease.Company overviewMetricValuePrice (as of market close May 14, 2026)$20.75Market capitalization$1.72 billionRevenue (TTM)$1.17 billionNet income (TTM)$57.25 million* 1-year performance is calculated using May 14, 2026 as the reference date.
Company snapshotFive9 offers a cloud-based contact center software platform supporting voice, video, chat, email, social media, and API integrations, with advanced features such as natural language processing and automatic speech recognition.It generates revenue through recurring subscriptions and usage-based fees for its virtual contact center solutions delivered as software-as-a-service (SaaS).The company serves enterprise and mid-market customers across industries including financial services, healthcare, technology, education, and business process outsourcing.Five9 operates at scale in the cloud contact center market, leveraging a SaaS model to deliver mission-critical communication solutions. The company’s strategy focuses on providing omni-channel customer engagement tools and AI-driven automation to help businesses improve customer experience and operational efficiency.
Its competitive edge lies in its robust technology stack, diversified client base, and strong presence across multiple industry verticals.
What this transaction means for investorsThe May 13 and May 14 sale of Five9 stock by Chief Administrative and Legal Officer Tiffany Meriweather came at a time when shares rebounded from a 52-week low of $13.29 reached in April. It appears Meriweather was capitalizing on the upswing to lock in gains.
The larger size of Meriweather’s sale compared to past transactions raises questions about her long-term outlook on Five9 stock. That said, she maintained a sizable equity stake of over 280,000 directly-held shares post-disposition.
Five9 shares have declined over the past year due to investor fears that artificial intelligence will take business away. AI agents can address some of the contact center functionality Five9 currently charges for.
However, the company’s excellent first-quarter performance caused shares to rise. Revenue increased 9% year over year to $305.3 million, demonstrating no impact from AI. In addition, Five9 did an outstanding job managing costs, resulting in Q1 net income of $18.4 million. This is a dramatic improvement from the prior year’s net income of $0.6 million.
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Five9. The Motley Fool has a disclosure policy.
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at First BanCorp (FBP - Free Report) , which currently has a Momentum Style Score of B. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. First BanCorp currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market? In order to see if FBP is a promising momentum pick, let's examine some Momentum Style elements to see if this holding company for FirstBank Puerto Rico holds up.
Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It's also helpful to compare a security to its industry; this can show investors the best companies in a particular area.
For FBP, shares are up 4.85% over the past week while the Zacks Banks - Foreign industry is up 3.44% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 7.6% compares favorably with the industry's 6.47% performance as well.
While any stock can see its price increase, it takes a real winner to consistently beat the market. That is why looking at longer term price metrics -- such as performance over the past three months or year -- can be useful as well. Shares of First BanCorp have increased 20.54% over the past quarter, and have gained 30.94% in the last year. On the other hand, the S&P 500 has only moved 12.48% and 26.22%, respectively.
Investors should also pay attention to FBP's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. FBP is currently averaging 1,462,921 shares for the last 20 days.
Earnings OutlookThe Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with FBP.
Over the past two months, 4 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost FBP's consensus estimate, increasing from $2.17 to $2.25 in the past 60 days. Looking at the next fiscal year, 3 estimates have moved upwards while there have been no downward revisions in the same time period.
Bottom LineTaking into account all of these elements, it should come as no surprise that FBP is a #2 (Buy) stock with a Momentum Score of B. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep First BanCorp on your short list.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Wesco International (WCC - Free Report) WESCO International, Inc. is one of the largest players in the highly fragmented distribution market for electrical construction products in North America.
WCC is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.
Momentum investors should take note of this Computer and Technology stock. WCC has a Momentum Style Score of A, and shares are up 0.5% over the past four weeks.
Five analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.39 to $15.94 per share. WCC boasts an average earnings surprise of +3.2%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, WCC should be on investors' short list.
Key Takeaways QuidelOrtho is poised for growth on its strong product portfolio and cost-saving progress.QDEL's Labs business leads first-quarter revenues, with Immunohematology and Point of Care adding support.Respiratory testing remains a key swing factor as lower demand pressures revenues and margins. QuidelOrtho Corporation (QDEL - Free Report) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by mixed first-quarter 2026 results, is expected to contribute further, along with progress in cost-saving initiatives. However, risks due to overdependence on the respiratory business persist.
This Zacks Rank #3 (Hold) company has lost 50.5% in the year-to-date period compared with the 23.2% decline of the industry. The S&P 500 has witnessed 10.5% growth in the said time frame.
The renowned rapid diagnostic testing solutions provider has a market capitalization of $993.5 million. QuidelOrtho’s earnings yield of 13.8% compares favorably with the industry’s 3.5%. The company surpassed the Zacks Consensus Estimate in two of the trailing four quarters, missed once and met estimates once, delivering an average negative surprise of 15.7%.
Image Source: Zacks Investment Research
Factors Favoring QDEL’s GrowthRobust Product Portfolio: QuidelOrtho’s diversified portfolio across Labs, Immunohematology, Point of Care and Molecular Diagnostics helps cushion demand fluctuations across testing categories. In the first quarter of 2026, Labs remained the largest revenue contributor at $353.1 million, followed by Immunohematology at $138.3 million and Point of Care at $112.8 million.
The company's Sofia platform and QuickVue franchise continue to provide scale in respiratory testing, with management noting stable market share during the quarter. For 2026, QuidelOrtho expects a typical flu season and stable testing protocols, with guidance based on a 50-55 million annual flu testing market and flat COVID-related revenues compared with 2025.
Growth initiatives remain focused on menu expansion and international penetration, with the U.S. launch of its high-sensitivity troponin assay already reaching more than 300 customer shipments and the rollout of the VITROS 450 system targeting lower-volume laboratories, which management believes can drive mid-single-digit long-term growth in the Labs business.
Progress on Cost-Saving Initiatives: QuidelOrtho is leveraging restructuring and productivity initiatives to expand margins and support investments in new platforms. In first-quarter 2026, adjusted operating expenses declined 2% year over year, led by a 19% reduction in R&D spending, while management reaffirmed its full-year adjusted EBITDA margin target of approximately 23%.
Through its Optimization Plan, the company is pursuing procurement efficiencies, facility consolidation and distribution rationalization, expecting around $50 million in net cost savings through 2027 despite cumulative pre-tax charges of about $100 million. QuidelOrtho is also implementing supply-chain measures to offset tariff-related cost pressures, while the wind-down of its U.S. Donor Screening business, expected to be substantially complete by mid-2026, and normalized working capital are projected to support stronger free cash flow generation in the second half of 2026.
Mixed Q1 Results: QuidelOrtho ended the first quarter of 2026 with mixed results, where revenues surpassed the Zacks Consensus Estimate, but earnings missed significantly. The company continued to witness strength in its Labs and Immunohematology business units, while solid growth across Latin America and resilient performance in EMEA and JPAC were encouraging.
However, persistent weakness in respiratory testing continued to weigh heavily on the top line, with Point of Care and Donor Screening businesses also posting sharp declines. The company’s bottom line deteriorated year over year, while gross and operating margins contracted significantly due to lower volumes and an unfavorable business mix.
Factors That May Offset the Gains for QDELOverdependence on Respiratory Segment: Respiratory testing remains a key swing factor for QuidelOrtho’s revenues and profitability despite the post-pandemic reset. First-quarter 2026 results were pressured by a milder and shorter respiratory season, with influenza-like illness visits declining roughly 30% year over year and respiratory revenues totaling $68 million. While management indicated that testing protocols and market share remained stable, suggesting the weakness was demand-driven rather than competitive, the lower respiratory contribution reduced product mix and contributed to a 630-basis point decline in adjusted gross margin.
For 2026, the company assumes a 50-55 million annual flu market and flat COVID revenues versus 2025, but still expects full-year respiratory revenues to decline, implying that even modest shifts in seasonality or testing volumes could continue to create significant variability in quarterly results and cash generation.
Estimate TrendQuidelOrtho is witnessing a stable estimate revision trend for 2026. In the past 30 days, the Zacks Consensus Estimate for its earnings has remained stable at $2.01 per share.
The Zacks Consensus Estimate for the company’s second-quarter 2026 revenues is pegged at $625.4 million, indicating 1.9% growth from the year-ago quarter’s reported number.
Key PicksSome better-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , West Pharmaceutical (WST - Free Report) and Intuitive Surgical (ISRG - Free Report) .
Globus Medical, currently flaunting a Zacks Rank #1 (Strong Buy), reported a first-quarter 2026 adjusted earnings per share (EPS) of $1.12 per share, which surpassed the Zacks Consensus Estimate by 22.1%. Revenues of $759.9 million beat the Zacks Consensus Estimate by 4.0%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GMED has an estimated long-term earnings growth rate of 10.2% compared with the industry’s 12.6% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 26.3%.
West Pharmaceutical, currently sporting a Zacks Rank #1, reported first-quarter 2026 EPS of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%.
WST has an estimated long-term earnings growth rate of 13.9% compared with the industry’s 9.5% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.4%.
Intuitive Surgical, carrying a Zacks Rank #2 (Buy) at present, reported first-quarter 2026 adjusted EPS of $2.50, which beat the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.
ISRG has a long-term estimated growth rate of 14.6% compared with the industry’s 12.6% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo smartSET™-powered, AI-enabled OIRD detection has received FDA 510(k) clearance for the Radius VSM® wearable continuous patient monitor.
